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ABSTRACT 
Poole, Nina Milan. Ph.D.  The University of Memphis.  May 2013.  The Global 
Effects of Tick Saliva on Host Cell Function.  Co-Major Professors: Lewis Coons, Ph.D. 
and Judith Cole, Ph.D. 
Hard ticks, such as Dermacentor variabilis, are obligate ectoparasites that remain 
attached to a host for up to 14 days.  To sustain this attachment, ticks must secrete 
bioactive molecules in their saliva to suppress the host’s immune, inflammatory, wound 
healing, and hemostatic responses.  Previously, we have shown that tick salivary gland 
extract and saliva have cell-specific effects on the function of NIH3T3-L1 fibroblasts and 
IC-21 macrophages.  Since cell migration is a pre-requisite for tumor invasion and 
metastasis, we investigated if saliva has global meaning general effects on the migratory, 
invasive, and signaling activities of Saos-2 osteosarcoma and MDA-MB-231 (MB-231) 
breast cancer cells. We determined that saliva inhibits Saos-2 and MB-231 migration and 
invasion. In Saos-2 cells, this inhibition correlated with suppressed epidermal growth 
factor (EGF) activation of Akt, however, only basal extracellular signal-regulated kinase 
(ERK) activity was affected in MB-231 cells. Initially, EGF receptor (EGFR) over-
expresssion masked the effect of saliva on MB-231 cells, but its ability to inhibit MB-231 
migration was comparable to the EGFR inhibitor PD 168393 and MEK inhibitor U0126.  
Prostaglandin E2 (PGE2), which is found in high concentration in tick saliva, decreases 
fibroblast migration and increases macrophage migration.  Therefore we examined if 
salivary PGE2 is responsible for the saliva-induced regulation of macrophage and 
fibroblast migration by using the PGE2 receptor antagonist, AH 6809.  Saliva increased 
platelet-derived growth factor (PDGF)-stimulated macrophage migration, a response 
reversed by AH 6809.  The inhibition of PDGF-stimulated fibroblast migration was also 
antagonist-sensitive.  Saliva induced macrophages to secrete PGE2, and conditioned 
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medium from these cells caused a PGE2 antagonist-sensitive inhibition of stimulated 
fibroblast migration.  In macrophages, we also showed that saliva decreases the secretion 
of the pro-inflammatory chemokine CCL5 and tumor necrosis factor-alpha (TNF-α) 
along with its soluble receptor (sTNFRI) through a PGE2-dependent mechanism mediated 
by cyclic adenosine monophosphate (cAMP).  Our findings indicate that the mechanisms 
ticks have evolved to regulate wound healing have generalized effects on cell migratory 
activities. These data also demonstrate how salivary PGE2 is utilized to regulate the 
activity of macrophages and fibroblasts, cells critically important in wound healing.  
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PREFACE 
This dissertation is presented as four chapters including two manuscripts.  Chapter 
one introduces the research and chapter four ties together the results from both 
manuscripts.  The second chapter contains the manuscript entitled “Effects of tick saliva 
on the migratory and invasive activity of Saos-2 osteosarcoma and MDA-MB-231 breast 
cancer cells” published in the journal Ticks and Tick-Borne Diseases volume 4 issues 1-
2, February 2013.  The third chapter contains the manuscript entitled “Prostaglandin E2 in 
tick saliva regulates macrophage cell migration and cytokine profile” submitted to the 
journal Parasites and Vectors, April 2013.  Both manuscripts are written in the format 
consistent with the guidelines set forth by the professional journal where they have been 
published or submitted.  Chapters one and four are referenced in accordance to the 
guidelines set forth by the journal Ticks and Tick-Borne Diseases.    
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Ticks (class Arachnida: subclass Acari: superorder Parasitiformes: order Ixodida) 
are obligate hematophagous nonpermanent ectoparasites of mammals, birds, reptiles, and 
amphibians in at least one stage of their life cycle.  Ticks are found on all continents of 
the world (Steen et al., 2006), and they transmit more pathogens (viruses, bacteria, and 
protozoa) than any other arthropod group (Dennis and Piesman, 2005; Singh and 
Girschick, 2003).  Worldwide, ticks have medical and veterinary importance (Ullmann et 
al., 2008) since they are a common vector for diseases that affect humans, livestock, and 
wildlife (Barker and Murrell, 2004; Singh and Girschick, 2003).  There are 907 valid tick 
species (Guglielmone et al., 2010) but only 10% are disease vectors or compromise the 
integrity of the skin during feeding therefore making their host more susceptible to 
secondary infections (Jongejan and Uilenberg, 2004).  Other injuries associated with tick 
parasitism include anemia and exsanguination for heavily parasitized hosts, dermatosis, 
toxicosis, paralysis, and anaphylaxis. The success of ticks as disease vectors is due to 
their feeding on multiple hosts, wide host ranges, long life spans, and the mechanism and 
length of time for feeding (Ullmann et al., 2008).  The mechanism utilized by ticks to 
acquire a blood meal requires laceration and penetration of the host’s skin with their 
mouthparts which remain embedded in the host for minutes or days depending on the 
species and life stage.    
The phylogenetic analyses of the Acari have proven difficult due to the lack of 
fossil evidence, specimens, and molecular data (Ullmann et al., 2008).  However, the 
superorder Parasitiformes consists of the orders Opiloacarida (mites), Holothyrida 
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(mites), Mesostigmata (mites), and Ixodida (ticks).  Ticks are monophyletic, and 
according to Klompen et al (2010 and 2000), Holothyrida (mites) and Ixodida (ticks) 
share a close relationship which suggests the origin of parasitism in ticks evolved from 
scavengers and not mesostigmatid-like nest predators.   It is understood that Ixodida 
consists of 3 families including Argasidae (soft ticks), Ixodidae (hard ticks), and the 
monospecific Nuttalliellidae (Guglielmone et al., 2010).   
The family Argasidae, termed soft ticks because of their flexible cuticle, consists 
of 193 species and 5 genera (Antricola, Argas, Nothoapsis, Ornithodoros, and Otobius) 
(Guglielmone et al., 2010).   Their cuticle is leathery with prominent mammillae to which 
the body muscles attach, and they lack sclerotized shields (Sonenshine, 1991).  In 
argasids, sexual dimorphism is not present (Coons and Alberti, 1999). Argasids feed on 
multiple hosts throughout their lifetime and even within a life stage (Ullmann et al, 
2008).  These ticks are short-term repetitive feeders that only feed for minutes to hours on 
their host.  They take up to 2-10 times their unfed body weight in blood depending on the 
stage and sex (Balashov, 1972); however, males take up a smaller blood meal than 
females. Almost all argasids concentrate the blood meal by excreting excess water and 
ions outside their body through paired coxal glands (Mans et al., 2011).  After dropping 
off the host, a female argasid lays multiple small batches of eggs (Ullmann et al., 2008). 
Most soft ticks are nidicolous in behavior and are closely associated with host nests or 
burrows.   
The Ixodidae or hard ticks, so called because of their heavily sclerotized cuticle, 
consists of 702 species and 14 genera (Ambylomma, Anomalohimalaya, Bothriocroton, 
Cosmiomma , Cornupalpatum, Compluriscutula, Dermacentor, Haemaphysalis, 
  3 
 
Hyalomma, Ixodes,  Margaropus, Nosomma, Rhipicentor, and Rhipicephalus) 
(Guglielmone et al., 2010).  They have a sclerotized plate on their anterior dorsum termed 
a scutum that serves as a site of attachment for body muscles (Sonenshine, 1991).  Ixodid 
ticks exhibit sexual dimorphism as only females have an alloscutum which consists of 
specialized folds that expand when she feeds (Coons and Alberti, 1999).  In contrast to 
argasids, ixodids feed on 1-3 hosts throughout their lifetime for 3-14 days depending on 
the species and life stage (Ullmann et al., 2008).  In addition, ixodids only feed once 
during each life stage and then molt to the next stage (Ullmann et al., 2008).  During 
feeding, females can take up as much as 100 times of their unfed body weight (Coons et 
al., 1986; Kaufman, 1983; Tatchell, 1967) while males only take in approximately 2 
times their unfed body weight.  Ixodid ticks lack coxal glands as seen in argasids (Coons 
et al., 1986; Kaufman, 1983; Tatchell, 1967).   Therefore, the blood meal is concentrated 
by excreting excess water and ions through the salivary glands and into the host as 
hyposmotic saliva; thus the actual blood meal can be greater than 200 times the unfed 
body weight in females (Coons et al., 1986; Kaufman, 1983; Tatchell, 1967).  The 
feeding process in adult female ixodids is divided into a slow feeding period which takes 
up to 7-8 days and a rapid engorgement period of 24-48 hours which only takes place if 
the female is inseminated (Coons and Albert, 1999).  Once a female ixodid completes a 
blood meal and drops off the host, she lays a single batch of eggs that may range in the 
tens of thousands depending on the species and dies shortly thereafter (Ullmann et al., 
2008). 
  The Ixodidae is separated into two divisions: Prostriata and Metastriata 
(Sonenshine, 1991).  Prostriata contains one genus, Ixodes, and ticks in this division mate 
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either on or off the host (reviewed in Kiszweski et al., 2001).  Many species of Ixodes 
have a limited host range and often show poorly developed host-seeking behavior. The 
Metastriata contains all other genera and these ticks mate on the host only after feeding 
begins (reviewed in Kiszweski et al., 2001).  All metastriate ticks have well developed 
host-seeking behaviors with most species ambushing their host and a few actively 
seeking their host.    
The Nuttallielidae is the most primitive of the 3 tick families and consists of only 
1 species, Nuttalliella namaqua, which is considered a living fossil (Mans et al., 2011).  
Groups have shown nuttallids share similar characteristics with the other 2 tick families 
(Latif et al., 2012; Mans et al., 2011).  As in argasids, nuttallids have a multiple host life 
cycle (Mans et al., 2011), rapid feeding (Mans et al., 2011), off host mating, a similar 
leathery cuticle (El Shoura, 1990; Keirans, 1976), and females lay multiple small batches 
of eggs (Latif et al., 2012).  Ixodid characteristics include the absence of coxal glands 
(Mans et al., 2011), larvae have a sclerotized scutum (Latif et al., 2012), and during all 
life stages the ability to climb smooth surfaces (Latif et al., 2012).  The monospecific 
Nuttallielidae has been instrumental in establishing facts about the other tick families.  A 
phylogenetic analyses using 16S mitochondrial rRNA and 18S nuclear rRNA placed 
Nuttallielidae basal to Argasidae and Ixodidae which further supports the monophyletic 
origin of ticks and suggests blood-feeding originated in an argasid-like ancestral tick 
lineage (Mans et al., 2011).   
Unlike mosquitoes, who insert their proboscis directly into the host’s capillary, 
ticks are pool feeders that establish a specialized feeding lesion which fills with blood 
from lacerated capillaries.  During the feeding process, ticks continuously alternate 
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between ingesting blood and salivating into the host (Coons and Alberti, 1999; 
Sonenshine, 1991; Kemp et al., 1982).  Consequently, ixodid ticks have a very complex 
feeding process that requires physical attachment to the host for an extended period of 
time in contrast to the short-term feeders, argasids and nuttallids. They secrete a cement-
like substance from their salivary glands into the host that hardens to aid attachment to 
the host, seals the feeding lesion to prevent fluid loss, and enhances blood sucking by the 
pharyngeal pump (Coons and Alberti, 1999; Sonenshine, 1991; Kemp et al., 1982).  The 
mechanical damage to the host’s skin from the tick’s mouthparts during feeding should 
elicit the host’s immune, inflammatory, hemostatic, and wound healing responses as 
similar objects of the same size; however these typical responses do not occur.  Tick 
saliva which contains a cocktail of immunomodulatory, anti-inflammatory, anti-
hemostatic, and anti-angiogenic components is the most well-studied mechanism utilized 
by ticks to subvert these host responses (Fontaine et al., 2011; Anderson, 2010; Nuttall 
and Labuda, 2008; Brossard and Wikel, 2008; Anderson and Valenzuela, 2008; Steen et 
al., 2006; Sauer et al., 1995; Ribeiro, 1995 and 1987).  The saliva not only provides a 
means by which ticks dampen the host responses to allow feeding until repletion, but it 
also permits ticks to transmit a variety of pathogens to humans and animals by enhancing 
the pathogenicity of agents, a process referred to as saliva-activated transmission of 
pathogens (Nuttall and Labuda, 2004; Jones et al., 1992). 
The goal of several studies has been to identify and characterize the molecules in 
saliva that modulate host responses. According to Steen et al. (2006), 50 biologically 
active salivary components, mostly proteins, have been identified.  Tick salivary 
component(s) have immunosuppressive effects on cells involved in innate immunity such 
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as neutrophil recruitment (Guo et al., 2009), apoptosis (Beaufays et al., 2008), adherence 
(Montgomery et al., 2004), and phagocytosis (Ribeiro et al., 1990).  Natural killer cell 
activity is also decreased (Kopecký and Kuthejlová, 1998 and Kubeš et al., 1994).  In 
antigen-presenting cells, saliva reduces macrophage cytokine production (Brake et al., 
2012; Chen et al., 2012), phagocytosis (Kramer et al., 2011), co-stimulatory molecule 
expression (Brake et al., 2012 and 2010), nitric oxide production (Kopecký and 
Kuthejlová, 1998), and inhibits dendritic cell maturation, differentiation, and cytokine 
production (Oliveira et al., 2011; Sá-Nunes et al., 2007; Cavassani et al., 2005).  There 
are molecules in tick saliva that regulate angiogenesis and wound healing to aid feeding 
(Hajnická et al., 2011; Francischetti, 2010; McEachron and Mackman, 2009; Carneiro-
Lobo et al., 2009; Francischetti et al., 2005) and that control cell migration by altering 
host cell signaling (Poole et al., 2013; Kramer et al., 2011and 2008) and the activity of 
chemokine binding proteins (Vančová et al., 2010; Dias et al., 2009; Dѐruaz et al., 2008; 
Hajnická et al., 2005; Vančová et al., 2007; Frauenschuh et al., 2007).   
In our studies, we used Dermacentor variabilis commonly known as the 
American dog tick as our model organism.  D. variabilis is a 3-host metastriate tick 
(Ullmann et al., 2008), and is the vector for Rocky Mountain spotted fever, tularemia, 
and tick paralysis.  We have shown that tick salivary constituent(s) inhibit platelet-
derived growth factor (PDGF)-stimulated fibroblast migration, possibly through the 
inhibition of extracellular signal-regulated kinase (ERK) (Kramer et al., 2008).  Salivary 
gland extract decreases injury repair and growth factor-induced signaling in renal cells, 
indicating that cells not involved in dermal wound healing were affected by the 
components in tick saliva (Kramer et al., 2008). Tick saliva suppresses the phagocytic 
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activity of macrophages but increases PDGF-stimulated macrophage migration (Kramer 
et al., 2011).  Therefore from these observations, it appears tick salivary constituent(s) 
have distinctive and cell-specific effects on cellular activities.  
Since we established that tick saliva regulates the migratory activity of cells 
crucial to the wound healing response, the first objective of this study was to determine if 
the saliva-induced effect on cell migration was global meaning this regulation by saliva 
extends to different cell types.  Therefore, we measured the effects of saliva on the 
migration of mesenchymal Saos-2 osteosarcoma cells and epithelial MDA-MB-231 
adenocarcinoma breast cancer cells. These cell lines were selected because they differ in 
embryonic origin and their expression of the epidermal growth factor receptor (EGFR), 
as this receptor and its downstream effectors are associated with the migratory activity of 
different cancer cells (Liu et al., 2012; Gan et al., 2010; Zhou et al., 2006; Price et al., 
1999).   
Upon completing these experiments, we focused on cells involved in host 
responses that could prevent or alter a tick’s ability to complete a blood meal. 
Macrophages are key regulators of the inflammatory and immune responses as they 
secrete numerous cytokines that modulate the activity of T lymphocytes.  During wound 
healing, macrophages trigger the proliferative phase by releasing cytokines and growth 
factors such as PDGF into the injury site.  PDGF secreted by macrophages, recruits 
fibroblasts to the injury where they proliferate, deposit precursors of the extracellular 
matrix, and lay down new collagen.  Prostaglandin E2 (PGE2), a potent modulator of 
inflammation and migration, is found in high concentration in tick saliva.  Therefore, our 
second objective was to investigate the role of salivary PGE2 on the regulation of IC-21 
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murine macrophage and NIH3T3-L1 murine fibroblast migration.  The PGE2 in the saliva 
of other tick species (Bowman et al., 1996; Urioste et al., 1995; Inokuma et al., 1994; 
Ribeiro et al., 1992 and 1985; Higgs et al., 1976) and has been shown to inhibit dendritic 
cell differentiation, maturation, and function (Oliveira et al., 2011; Sá-Nunes et al., 2007) 
and T lymphocyte proliferation (Inokuma et al., 1994).  To our knowledge, the PGE2 
content in D. variabilis saliva has not been measured nor evaluated for its effects on 
immune or reparative cell function.   
From these studies, our goal was to demonstrate that the saliva-induced 
modulation of host cell function is not restricted to immune and reparative cells, but 
extends globally to cells with similar functions such as the migratory and invasive 
activities of metastatic cancer cells.  By expanding the scope of our investigation into 
PGE2 as the tick salivary constituent responsible for the changes in macrophage and 
fibroblast migration, we may establish a potential mechanism ticks utilize to regulate the 
type of cells present near the feeding lesion.  Our evaluation of the effects of saliva on 
macrophage cytokine production will indicate how ticks are able to control host 
inflammatory and immune responses that would usually lead to removal or rejection.  
Collectively, these studies will highlight the potential mechanisms ticks utilize to regulate 
the complex host-parasite interaction. A broader implication of our work is providing 
new information that can be used in combating tick-borne agents which are an important 
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CHAPTER 2 
Effects of tick saliva on the migratory and invasive activity of Saos-2 osteosarcoma 
and MDA-MB-231 breast cancer cells  
Introduction 
 Female ixodid ticks such as Dermacentor variabilis have a complex feeding 
process that requires physical attachment to the host for an extended period of time.  
After establishing a specialized feeding lesion beneath the host’s dermis, ticks alternate 
between ingesting blood and secreting saliva into the host (Coons and Alberti, 1999; 
Sonenshine, 1991; Kemp et al., 1982).  To complete feeding, a tick must subvert the 
host’s immune, hemostatic, inflammatory and wound healing responses using the 
numerous bioactive compounds in tick saliva (Hajnická et al., 2011; Kramer et al., 2011; 
Oliveira et al., 2011; Vančová et al., 2010; Anderson, 2010; Francischetti, 2010; 
Carneiro-Lobo et al., 2009; Dias et al., 2009; Guo et al., 2009; McEachron and 
Mackman, 2009; Kramer et al., 2008; Brossard et al., 2008; Anderson et al., 2008; 
Dѐruaz et al., 2008; Nuttall and Labuda, 2008; Frauenschuh et al., 2007; Sá-Nunes et al, 
2007; Vančová et al., 2007; Francischetti, et al., 2005; Cavassani et al., 2004).  Previous 
studies in our laboratory show that  tick salivary gland extract inhibits platelet-derived 
growth factor (PDGF)- stimulated fibroblast migration and suggest that the inhibition of 
extracellular signal-regulated kinase (ERK) is involved (Kramer et al, 2008).  However, 
saliva increased PDGF-stimulated macrophage migration without affecting ERK activity 
and suppressed their ability to phagocytose which is important for proper wound healing 
to occur (Kramer et al., 2011).     
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 Metastasis is the process whereby cancer cells spread from the primary tumor to 
distant locations where secondary tumors develop.  Acquiring motility is crucial for 
noninvasive cells to become metastatic (Price et. al, 1997). Normal cell migration is a 
multi-step process regulated in part by signal transduction.  The same signaling proteins 
utilized by normal cells to migrate are also used by cancer cells to increase their motility.  
The epidermal growth factor receptor (EGFR) and the downstream targets associated 
with this receptor such as ERK and Akt/Protein Kinase B can regulate the migratory 
activity of cancer cells (Liu et al., 2012; Gan et al., 2010; Zhou et al., 2006; Price et al., 
1999).  Since tick saliva constituent(s) modulate the migratory and signaling activities of 
cells involved in the wound healing response, we wondered if it had global effects on the 
migratory and invasive activities of cancer cells.  
In this study, we evaluated the effects of saliva on the migratory, invasive, and 
signaling activities of two distinct types of cancer cells.  The mesenchymal Saos-2 cells 
are a non-transformed cell line derived from a primary osteosarcoma that retain several 
osteoblastic properties while the epithelial MDA-MB-231 (MB-231) adenocarcinoma 
breast cancer cell line was originally derived from the pleural effusion between the layers 
of tissue that line the lungs and chest cavity.  Unlike the Saos-2 cells, the highly invasive 
MB-231 cells over-express the EGFR (Davidson et al., 1987) and can develop metastases 
in nude mice (Price et al., 1990).  The use of these two different cell lines in our study 
will provide more information of the potential global effects induced by tick saliva on 
cell migration.    
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Materials and methods 
Cell culture 
  Saos-2 osteosarcoma cells were a generous gift of Dr. Sayed Khundmiri, 
University of Louisville School of Medicine, Louisville, KY and were maintained in 25 
or 75 cm
2
 flasks (Corning Inc., Corning, NY) in McCoy’s medium (MediaTech, 
Herndon, VA)  supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin 
and 100 μg/ml streptomycin.  NIH3T3-L1 dermal fibroblasts were a generous gift of Dr. 
Peter Wilden, University of Missouri School of Medicine, Columbia, MO and were 
grown in 25 or 75 cm
2 
flasks in Dulbecco’s modified Eagle’s medium nutrient mixture F-
12 (DMEM/F12) (MediaTech, Herndon, VA) supplemented with 10% FBS, 100 U/ml 
penicillin and 100 μg/ml streptomycin.  MDA-MB-231  breast cancer cells were obtained 
from American Type Culture Collection (ATCC, Manassas, VA) and maintained in 25 
cm
2
 flasks or 100 mm dishes in Dulbecco’s modified Eagle’s medium (DMEM) 
(MediaTech, Herndon, VA) supplemented with10% FBS, 100 U/ml penicillin and 100 




 free Hank’s 
balance salt solution (HBSS) and 0.025% trypsin/0.02% EDTA (Mediatech, Herndon, 
VA).  All cell lines were seeded at a density of 5 x 10
4 
cells/ml.  
Collection of tick saliva 
Adult male and female ticks were either purchased from the Tick Rearing Facility 
at Oklahoma State University or were a generous gift from Dr. Daniel Sonenshine, Old 
Dominion University, Norfolk, VA.  Male and female ticks were fed on naive female 
New Zealand white rabbits (Mrytle’s Rabbitry, Thompson’s Station, TN) for 5-8 days 
following protocols approved by The University of Memphis Institutional Animal Care 
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and Use Committee.  Partially engorged females (80-350 mg) were removed and attached 
to a slide with double-sided adhesive tape.  Female ticks were injected with 10 μl of 
MOPS buffered tick saline pH 7.0 containing 10 mM dopamine / 10 mM theophylline 
with 3% DMSO (Needham and Sauer, 1979).  Ticks that failed to secrete saliva by 5 min 
post-injection were not used.  Ticks secreting saliva were injected a total of 3 times in 5 
min intervals with TS/MOPS (10 µl) and saliva was collected in a 5, 10, or 25 µl non-
heparinized soda lime glass micropipette. Total protein concentration of saliva was 
determined using a Bio-Rad Protein Assay based on the method of Bradford (Bio Rad 
Laboratories, Hercules, CA) and stored at -20
◦
C until used. 
Western blot 
Total protein for Saos-2 and MB-231 cells was quantified using a Bio-Rad Protein 
Assay based on the method of Bradford and was diluted in SDS-PAGE sample buffer. 
Equal amounts of proteins were separated on 7.5% SDS-PAGE Tris-glycine gels and 
transferred to Optitran nitrocellulose membranes (Whatman Inc., Sanford, ME). Blots 
were blocked with Super blocking buffer phosphate buffered saline (PBS) (Pierce 
Biotechnology, Rockford, IL) containing  0.05% Tween-20 for 1 h then incubated 
overnight with mouse anti-EGFR primary antibody (1:1000) (BD Biosciences 
Pharmingen, San Diego, CA), and then incubated with 1:1000 HRP-conjugated goat anti-
mouse IgG (Cell Signaling Technology Inc., Beverly, MA). Blots were washed and 
developed with SuperSignal West Pico Chemiluminescent Substrate (Pierce 
Biotechnology, Rockford, IL) and images developed on Classic Blue Autoradiography 
Film X (Molecular Technologies, St. Louis, MO). 
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Cell migration assay 
The effects of tick saliva on Saos-2 and MB-231 basal and stimulated migration 
were evaluated using blind well chamber assays (Neuro Probe, Gaithersburg, MD).  In 





 free HBSS and trypsinization for 5 min. Cells were resuspended in 
serum-free medium, counted, and diluted to a concentration of 1 x 10
5
 cells/ml. The 
bottom chamber of the blind well was loaded with either serum-free medium, medium 
with 10% FBS or medium with 100 ng/ml epidermal growth factor (EGF) (Bachem 
Americas, Torrance, CA) as the chemoattractant.  An 8 µm polycarbonate filter without 
matrix proteins (Neuro Probe, Gaithersburg, MD) was inserted between the bottom and 
upper chambers and the upper chamber was loaded with 100 µl of the cell suspension 
pretreated for 30 min with vehicle, saliva (0.4, 0.8, 1.0  or 3.0 µg protein/ml), the EGFR 
tyrosine kinase inhibitor PD 168393 (1 µM; Calbiochem-EMD4Biosciences, La Jolla, 
CA), the MEK1 and 2 inhibitor U0126 (100 nM; Tocris Bioscience, Minneapolis, MN) or 
co-treatments with saliva and inhibitors.  After a 4 h incubation at 37
◦
C in humidified air 
with 5% CO2,   the non-migratory cells on the upper surface of the filter were removed 
with a cotton-tip applicator and the cells on the lower surface of the filter were fixed with 
100% methanol and stained with 0.4% crystal violet in 4% ethanol.  The filters were 
mounted on glass microscope slides and the cells were counted in five random high-
power (40x) fields using a Nikon Labophot light microscope.  Data were reported as the 
percentage of control cells migrating in the absence of chemoattractant. 
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Matrigel invasion assay 
The effects of saliva on Saos-2 and MB-231 invasiveness were assessed using a 
24-well plate BD BioCoat Matrigel Invasion Chamber (BD Biosciences, Bedford, MA).  
This assay consists of inserts containing 8 µm pore size polyethylene terephthalate 
membranes coated with a thin layer of matrigel, a reconstituted basement membrane 
which prevents non-invasive cells from migrating through the pores of the membrane.  In 
contrast, invasive cells are able to detach themselves, invade, and migrate through the 
matrigel coated membrane.  Experiments were performed according to manufacturer’s 
instructions which require the use of invasive control cells such as NIH3T3-L1 fibroblast 
to determine the invasive potential of test cells. Cells were trypsinized, counted, and 
resuspended at 5 x 10
4 
cells/ml and 750 µl of medium with 10% FBS as the 
chemoattractant was added to each well.  The uncoated polyethylene terephthalate control 
or rehydrated matrigel membrane inserts were aseptically transferred to each well and 
500 µl of cell suspension treated with vehicle or increasing amounts of saliva (0.1, 0.2 or 
0.4 µg protein/ml) was loaded to the upper well.  The plate was incubated for 36 h at 
37
◦
C in humidified air with 5% CO2.  After the incubation period, the non-invading cells 
were removed from the upper surface of the filters with a cotton-tip applicator and the 
cells on the lower surface of the matrigel coated or uncoated control inserts were fixed 
with 100% methanol, stained with 0.4% crystal violet in 4% ethanol, and counted in five 
random high-power (40x) fields using a Nikon Labophot light microscope.  Data were 
reported as the percentage of control invading cells.   
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Cell number assay 
Cell number was determined colorimetrically using the CellTiter® AQueous One 
Solution Cell Proliferation Assay (Promega, Madison, WI) that utilizes a tetrazolium 
compound (MTS) and an electron coupling agent (phenazine ethosulfate).  Saos-2 and 
MDA-MB-231 cells were cultured in 96-well plates and changed into serum-free medium 
with 0.1% bovine serum albumin (BSA) 24 h prior to each experiment.  Cells were 
treated with vehicle or saliva (0.1, 0.2, 0.4 or 1.0 µg protein/ml) for 0, 24 and 48 h.  Then 
20 µl of MTS was added to each well and incubated for 2 h.  Live cells reduce MTS to a 
soluble formazan product that is directly proportional to the number of viable cells.  A 
standard curve of known cell number was added to the 96-well plate prior to addition of 
MTS to determine cell number.  Absorbance was read at 490 nm using a Bio-Tek Elx808 
Ultra Microplate Reader.  After cell number was determined, data were reported as the 
percentage of control cells at 0 h.  
  Phosphoantibody cell-based ELISA (PACE) 
ERK and Akt activation were measured using the phosphoantibody cell-based 
ELISA (PACE) described in Kramer et al. (2008). Cells grown in 96-well plates were 
changed to serum-free medium 24 h prior to each experiment. Cells were pretreated for 
30 min with vehicle, saliva (0.1, 0.2, 0.4, 1.0 or 3.0 µg protein/ml), 1 µM EGFR tyrosine 
kinase inhibitor PD 168393, 100 nM MEK inhibitor U0126 or co-treatments with saliva 
and inhibitors.  Stimulated ERK or Akt activity was determined by challenging with 1, 10 
or 100 ng/ml EGF for 15 min. Experiments were stopped by adding ice-cold PBS to each 
well. Cells were washed once with PBS and fixed in 4% formaldehyde.  After blocking 
with 5% BSA (anti-Akt antibody) or 5% nonfat dry milk (anti-ERK antibody) in PBS 
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containing 0.1% Triton X-100 (PBS-T), the cells were incubated overnight at 4
◦
C in 
activation-specific phospho-Akt (Ser473) antibody (1:500) or phospho-ERK 
(Thr202/Try204) antibody (1:8000) (Cell Signaling Technology Inc., Beverly, MA). 
Plates were then washed 3 times with PBS-T, incubated for 1 hr with an HRP-conjugated 
secondary antibody, and developed with 1-Step Ultra TMB ELISA substrate (Pierce 
Biotechnology, Rockford, IL).  Absorbance was read at 450 nm using a Bio-Tek Elx808 
Ultra Microplate Reader; data were normalized to the absorbance in controls and reported 
as the fold change in Akt and ERK activity. 
Statistical analysis 
PACE data are means ± SEM of 3-4 experiments assayed in triplicate and 
performed over several passages of cells.  Data were normalized to the absorbance in 
vehicle matched controls and reported as the fold change over basal. Cell migration, 
invasion, and number data are percentage of control values ± SEM of 3-4 experiments.  
Statistical significance was determined by one-way ANOVA; Student Newman-Kuels 
and Dunnett’s post tests were used for multiple comparisons employing Graph Pad Prism 
version 3.02 Windows (Graph Pad Software, San Diego CA, www.graphpad.com).  
Differences in means were considered significant at p≤ 0.05.  
Results     
  To assess the effect of tick saliva on cell migration, we used blind well assays to 
measure the cell movement across an uncoated filter with 8 µm pores.  Saos-2 and MB-
231 cells were pretreated with saliva for 30 min then loaded into the upper chamber of 
the blind well chemotaxis chamber where the lower chamber was loaded with serum-free 
medium or medium containing 10% FBS.  After a 4 h incubation, saliva (0.8 µg 
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protein/ml) reduced basal Saos-2 migration by 42.2 ± 5.2% (Fig. 1A).   FBS increased 
Saos-2 cell migration by 38.1 ± 13.5% a response that was dose-dependently reduced by 
32.8 ± 12.4 and 51.9 ± 11.2% for 0.4 and 0.8 µg protein/ml respectively (Fig. 1A). Fig. 
1B illustrates how saliva decreases the number of migrating Saos-2 cells when compared 
to control.   Saliva had no effects on MB-231 basal migration; however there was a 









  24 
 
 
Fig. 1.  Effect of tick saliva on Saos-2 and MDA-MB-231 migration.  Saos-2 and MB-
231 cells were pretreated with vehicle (PBS) or saliva for 30 min, then incubated for 4 h 
in the absence or presence of FBS in the lower chamber. (A) Saliva dose-dependently 
decreases basal and FBS-simulated Saos-2 migration (a) p<0.05 when compared to 
vehicle control only, (b) p<0.01 and (c) p<0.001 when compared to FBS without saliva.  
(B) Images represent the saliva-induced inhibition on FBS-stimulated Saos-2 migration 
when compared to control. Data are reported as the % control values and are  means + 
SEM, n=number of times repeated, n=4. (C) Saliva does not inhibit MB-231 migration 
but FBS-stimulated migration increases in the presence of tick saliva.  Data are means + 
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EGF is a growth factor which enhances the migratory activity of numerous cell 
types by binding to the EGFR and stimulating its tyrosine kinase activity (Han et al., 
2010; Dise et al., 2008; Price et al., 1999).  The EGFR gene is frequently mutated and the 
protein is over-expressed in cancer cells (da Cunha Santos et al., 2011; Teng et al., 2011, 
Davidson et al., 1987).  Since MB-231 cells are reported to over –express the EGFR 
(Davidson et al., 1987) and responded differently to saliva than did Saos-2 cells, we first 
compared the level of EGFR expression to see if differences in receptor number might be 
masking the effects of saliva on the breast cancer cells.  Western blot analysis of 10, 20, 
and 40 µg protein of whole-cell extracts confirms greater EGFR protein levels (170 kDa) 
in MB-231 breast cancer cells than in Saos-2 osteosarcoma cells (Fig. 2A).    
A previous study in MB-231 cells has shown that EGF stimulates a potent 
migratory response, and inhibition of ERK 1and 2 by the MEK inhibitor, PD 098059 
reduces basal migration (Price et. al, 1999). Therefore, we assessed how decreasing 
EGFR and ERK activity would affect the ability of saliva to alter MB-231 migration.  
Pretreatment for 30 min with saliva decreased basal MB-231 migration by 44.4 ± 8.1% 
and 49.8 ± 9.4% for 1.0 and 3.0 µg protein/ml respectively (Fig. 2B).  Reducing EGFR 
activity with 1µM PD 168393 decreased basal migration by only 27.9 ±5.5%, while cells 
treated with both PD 168393 and saliva (3.0 µg protein/ml) decreased basal migration by 
68.9 ± 7.6% (Fig. 2B).  Similarly, 100 nM U0126 reduced basal migration by 41.7 ± 
8.8% while co-treatment with saliva and U0126 reduced migration by 73.8 ± 1.7% (Fig. 
2B).  Treatment with saliva (0.8 µg protein/ml) or saliva+PD 168393 were more effective 
at reducing EGF-stimulated MB-231 migration (48.8 ± 8.1%  and 53.0 ± 9.0%  of control 
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respectively) than  PD 168393 alone (58.7 ± 12.3%) when compared to vehicle control 
only (Fig. 2B).   
 
Fig. 2. The EGF receptor (EGFR) and ERK activity play a role in regulating the 
migration of MB-231 cells.  (A) Western blot analysis of 10, 20, and 40 µg protein of 
whole-cell extracts demonstrates greater EGFR protein levels in MB-231 breast cancer 
cells than in Saos-2 osteosarcoma cells. MB-231 cells were pretreated for 30 min with 
vehicle (DMSO), saliva,  the EGFR inhibitor PD 168393 (1 µM), the MEK/ERK 
inhibitor U0126 (100 nM)  or co-treatments with saliva and inhibitors then migration was 
measured 4 h later.  (B) Tick saliva decreased basal MB-231 migration and both 
inhibitors were  more effective at reducing basal migration in the presence of saliva than 
when used alone.  (a) p<0.05 when compared to U0126 alone, (b) p<0.01 when compared 
to PD 168393 alone, and (c) p<0.001 when compared to vehicle. (C) Saliva more 
effectively decreased EGF-stimulated MB-231 migration than PD 168393 (a)  p<0.05 and 
(c) p<0.001 when compared to vehicle control only. Data in (B) and (C) are reported as 
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The ability of the cancer cells to invade the basement membrane and penetrate 
healthy neighboring tissue and blood vessels is crucial to the development of metastatic 
disease.  To evaluate the effects of saliva on the invasive potential of Saos-2 and MB-231 
cells, we used a matrigel invasion assay. Matrigel is a gelatinous protein mixture that 
resembles the extracellular matrix in composition and stimulates cells to produce 
proteases for degradation.  Saos-2 and MB-231 cells were pretreated for 30 min with 
saliva then loaded into the upper well of the chamber; the lower well of the chamber was 
loaded with medium containing 10% FBS as the chemoattractant.  After a 36 h 
incubation, saliva dose-dependently decreased Saos-2 invasiveness by 38.3 ± 3.9%, 44.6 
± 3.8%, and 62.9 ± 2.1% (Fig. 3A).  Saliva effectively reduced MB-231 invasiveness by 
52.1 ± 4.8%, 33.0 ± 7.8%, and 39.1 ± 5.7% respectively for 0.1, 0.2, and 0.4 µg 
protein/ml (Fig. 3B).  MB-231 invasion was maximally inhibited by 0.1 µg protein/ml 
and increasing saliva concentration produced no greater effects (Fig. 3B).  Saliva with the 
highest protein concentration reduced the invasiveness of the control NIH3T3-L1 
fibroblasts by 60.0 ± 4.0% (Fig. 3C).   These data indicate tick saliva reduces FBS-





































Fig. 3. Tick saliva inhibits invasiveness of Saos-2 and MB-231 cells.  Saos-2, MB-231 
and NIH3T3-L1 cells were pretreated with vehicle (PBS) or saliva for 30 min then 
exposed to a chemotactic signal provided by 10% FBS for 36 h.  The migration of cells 
through the matrigel-coated filter was determined 36 h later.  (A) Tick saliva dose-
dependently decreased FBS-stimulated Saos-2 invasiveness. (B) Saliva decreases FBS-
stimulated MB-231 invasiveness with the maximum effective dose reached with saliva 
containing the lower protein concentration.  (C) Saliva also dose-dependently decreases 
FBS-stimulated invasiveness of the control cells, NIH3T3-L1 fibroblast. Data are 
reported as % control invasiveness and are the means ± SEM, n=3 assayed in triplicate. 
(c) p< 0.001 compared to vehicle control.   
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One explanation for the decrease in migration and/or invasion is that saliva kills a 
percentage of the cells.  To test this possibility, we examined the effect of saliva on cell 
number using a MTS cell viability assay. There was no change in cell number with the 
different amounts of saliva over 48 h (Fig. 4A and B).  We used a clonogenic assay to 
evaluate cell viability by colony formation which also supported the conclusion that 














Fig. 4.  Saliva does not affect Saos-2 or MDA-MB-231 cell number. (A) Saos-2 and 
(B) MB-231 cells were treated with saliva for 0, 24 and 48 h.  There was no significant 
reduction in cell number, n=3 assayed in triplicate.  Data are means ± SEM% of the 
control.   
 
 
Akt and ERK signaling can both mediate growth-factor induced cellular migration 
and aberrant regulation of Akt and ERK pathways can contribute to cancer phenotypes 
(Liu et al., 2012; Gan et al., 2010; Yoeli-Lerner et al., 2006; Zhou et al., 2006; Osaki et 
al., 2004; Hoshino et al., 1999).  Based on the observation that saliva inhibited Saos-2 
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and MB-231 migration and invasion, we wanted to determine if Akt or ERK signaling 
could be affected by tick saliva.  To test this hypothesis, we used PACE assays to 
determine the effect of saliva on basal and EGF-stimulated kinase activities.  Cells were 
pretreated for 30 min with increasing concentrations of saliva followed by a challenge 
with 1, 10, or 100 ng/ml EGF for 15 min (Fig. 5 and 6A).  In Saos-2 cells, saliva (0.4 µg 
protein/ml) significantly reduced EGF-stimulated Akt activity by 60.2 ± 0.3% (Fig. 5A) 
but had no significant effect on ERK activity.  Saliva had no effect on Akt (data not 
shown) or EGF-stimulated ERK activity in MB-231 cells (Fig. 6A). Since the saliva-
induced effects on basal and/or EGF-stimulated MB-231 migration were enhanced by the 
EGFR inhibitor PD 168393 and MEK inhibitor U0126, we used these inhibitors to 
evaluate the effects of saliva on ERK activity.  Pretreatment with saliva (3.0 µg 
protein/ml) for 30 min reduced basal ERK activity by 32.7 ± 0.062% (Fig. 6B).  
Decreasing EGFR activity with PD 168393 did not significantly reduce ERK activity in 
these cells but treatment with both PD 168393 and saliva (3.0 µg protein/ml) reduced 
ERK activity by 42.9 ± 0.023% (Fig. 6B).  Inhibition of MEK kinase activity by U0126,  
reduced ERK activity by 49.2 ± 0.092%  which was less than the 74.9 ± 0.062% 
reduction produced by both  U0126 and saliva (3.0 µg protein/ml) (Fig. 6B).  
 
  


















Fig. 5.  Effect of tick saliva on Akt and ERK activity in Saos-2 cells.  (A) Saos-2 cells 
were pretreated with vehicle (PBS) or saliva for 30 min then challenged with 1, 10 and 
100 ng/ml EGF for 15 min.  Saliva (0.4 µg/ml) decreases Akt activation at each 
concentration of EGF but significance (p< 0.05) was achieved at 100 ng/ml EGF,  (a) 
p<0.05 when compared to (0.0 µg/ml) at 100 ng/ml EGF. (B) Saliva has no significant 
effect on EGF-activation of ERK or basal activity in these cells. Data in (A) and (B) are 


































































































Fig. 6.  Tick saliva inhibits basal ERK activity and increases the effectiveness of PD 
168393 and U0126 in MB-231.  (A) MB-231 cells were pretreated with vehicle (PBS) or 
saliva for 30 min then challenged with 1, 10 and 100 ng/ml EGF for 15 min.  Saliva had 
no effect on EGF-induced ERK activation in these cells or a significant effect on basal 
activity at each concentration used.  (B) Cells were treated with vehicle (DMSO), saliva, 
PD168393 (1 µM), U0126 (100 nM) or co-treatments with saliva and inhibitors for 30 
min. 3 µg/ml saliva decreased basal ERK activity, a response enhanced by PD 168393 
and U0126.  Data are reported as fold change in basal ERK activity and are means + 
SEM, n=3 assayed in triplicate.  (a) p<0.05 when compared to U0126 alone, (b) p<0.01 
when saliva 3.0 µg/ml protein compared to vehicle and PD 168393+ saliva 3.0 µg/ml 
protein compared to PD 168393 alone, (c) p<0.001 when U0126+ saliva 3.0 µg/ml 
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Discussion 
Ticks have evolved mechanisms to selectively regulate cells involved in the 
wound healing response.  We have previously shown that tick salivary gland extract 
(SGE) inhibited PDGF- stimulated fibroblast migration (Kramer et al., 2008), a process 
required for fibroblasts to begin injury repair. Also, SGE reduced injury repair and 
growth factor-induced signaling in renal cells, indicating that cells not involved in dermal 
wound healing were affected by tick saliva constituents.  Tick saliva suppressed the 
phagocytic activity of macrophages while enhancing PDGF-stimulated macrophage 
migration (Kramer et al., 2011).  Thus, saliva appears to have varied and cell-specific 
effects on cellular activities including migration.  
  In this study we evaluated the effects of saliva from D. variabilis ticks on the 
migration, invasion, and signaling activities of Saos-2 osteosarcoma and MB-231 breast 
cancer cells.  Our results show that saliva inhibits FBS-stimulated Saos-2 migration but 
elicits a pro-migratory response in the MB-231 cells. Tick saliva contains high 
concentrations of lipid modulators such as prostaglandins (Oliveira et al., 2011; Sá-Nunes 
et al., 2007; Cavassani et al., 2004; Bowman et al., 1996) that increase migration in Saos-
2 and MB-231 cells (Zhao et al., 2011; Timoshenko et al., 2003).  Therefore it seems 
logical that the prostaglandins in tick saliva would elicit a pro-migratory response in both 
cells.  One explanation for the different effects on migration might be the chemical 
composition of the saliva.  Although we used saliva with the same total protein 
concentration, for each experiment, the concentration of specific protein and lipid 
constituent(s) that can modulate cell migration may vary as the pooled saliva was 
collected from many ticks of different feedings.  However, we do not believe that 
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differences in saliva constituents are responsible as SGE and saliva both inhibit fibroblast 
migration (Kramer et al, 2008 and Fig. 3C) consistent with reduced wound healing 
(Singer and Clark, 1999).  Enhanced macrophage migration is consistent with in vivo 
studies showing increased numbers of macrophages at the feeding lesion (Szabó and 
Bechara, 1999).  
An alternative explanation might be inherent differences in the signaling activities 
of the cells.  Saos-2 and MB-231 cells both express the EGFR that promotes migration 
when activated by EGF, but MB-231 cells have substantially more receptor protein than 
do Saos-2 cells (Davidson et al., 1987 and Fig 2A).  When we increased the dose of 
saliva, basal MB-231 cell migration was inhibited, a response that was enhanced by 
inhibiting EGFR signaling and ERK activity.  These data are consistent with studies 
showing that MB-231 migration is EGF- and ERK-dependent (Price et al., 1999). This 
suggests that the differences in saliva effects on migration were the result of MB-231 
requiring larger doses of saliva to interfere with what appears to be EGFR- and ERK-
dependent regulation of migration in these cells.   
For metastasis to occur, cancer cells must migrate and invade neighboring tissue 
and vasculature, a process that requires the degradation of extracellular matrix proteins.  
We observed a decrease in FBS-stimulated invasion in saliva-treated Saos-2 and MB-231 
cells.  While this response could reflect an effect of saliva on the number of viable cells, 
there was no impact on cell number even when Saos-2 and MB-231 cells were treated for 
48 with saliva.  Alternatively, the effect of saliva on invasion may reflect a lower number 
of cells migrating.  Saliva does suppress FBS-stimulated migration of Saos-2 cells, but a 
reduction in the number of cells migrating does not explain the saliva-induced inhibition 
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of FBS-stimulated MB-231 invasion as saliva is pro-migratory in these cells.  Invasion 
requires the activity of matrix metalloproteinases (MMPs) to degrade the extracellular 
matrix (Johnsen et al., 1998), and our invasion data, which reflect the ability of cells to 
cross an extracellular matrix-coated filter, suggest that MMP activities are suppressed by 
tick saliva.  In fact, saliva reduced the invasive activity of NIH3T3-L1 fibroblasts in our 
study and previous work with these cells has shown that saliva reduces the expression of 
(MMP)-2 and 9 (unpublished data).  In addition, inhibition of EGF-induced activation of 
(MMP)-9 resulted in suppressed migration and invasion of MB-231 cells (Tsai et al., 
2012) adding further support for a salivary constituent(s) inhibiting MMP activity.  We 
are currently investigating this hypothesis.    
Our analysis of Akt and ERK activity in Saos-2 and MB-231 cells supports the 
view that the effect of saliva on migration and invasion reflects changes in EGFR 
signaling. In the Saos-2 cells, agonist-induced activation of Akt plays a crucial role in cell 
migration (Coltella, et al., 2003), and we show that Akt activation by EGF is reduced by 
tick saliva.  ERK does not appear to play a role in migration in this cell line as saliva had 
no significant effect on basal or EGF-stimulated ERK activity.  Basal migration of MB-
231 cells is ERK- dependent but EGF-stimulated migration is PI3K- and PLC-dependent 
(Price et al., 1999).  Our data show that saliva had no effect on EGF-stimulated Akt and 
ERK activity in the MB-231 cells.  While our initial experiments showed no effect of 
saliva on basal migration or ERK activity in MB-231 cells, this was a function of saliva 
dose, not a lack of ERK-dependence.  In addition, the ability of the EGFR receptor 
inhibitor PD 168393 and the MEK inhibitor U0126 to reduce ERK activity in the MB-
231 cells support a role for the EGFR-dependent ERK activation as a target for regulation 
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by tick saliva.  Akt and ERK are both downstream effectors of EGFR-mediated cellular 
processes. If saliva is interfering with EGFR signaling, how is Akt or ERK affected while 
the other is not.  The specificity of the signaling pathway affected when saliva affects 
EGFR signaling in these cells is likely or at least in part due to the different signaling 
molecules recruited to the receptor.  The recruitment of signal molecules and the number 
of these molecules will in turn regulate which downstream pathways are activated and the 
duration of activation.     
In summary, this study provides further insight to how ticks regulate cell 
migration, invasion, and signaling which are important processes in controlling host 
cellular responses. Our data indicate that tick saliva constituent(s) are not limited to only 
regulating cells involved in the wound healing cascade but can modulate the migratory 
and invasive activities of other host cells such as cancer cells by interfering with signal 
transduction. 
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CHAPTER 3 
Prostaglandin E2 in tick saliva regulates macrophage cell migration and cytokine profile 
Background 
Ixodid ticks such as Dermacentor variabilis are obligate blood-sucking 
ectoparasites that physically attach to their host for several days to feed until repletion.  
The cutting action of the chelicerae, insertion of hypostome, and the rupturing of blood 
vessels [1-3] all result in localized damage to the host’s epidermis and dermis.  This 
mechanical damage to the host’s skin should elicit the host’s immune, inflammatory, 
hemostatic, and wound healing responses resulting in removal or rejection of the tick; but 
this is not the case.  Instead, ticks use a cocktail of bioactive molecules in their saliva to 
evade these host responses [4-12].  
Tick saliva has been shown to regulate the migratory activities of distinct cell 
types by modulating cell signaling [13-15] and the activity of chemokine binding proteins 
[16-21].  Tick salivary constituent(s) have suppressive effects on innate immunity by 
regulating neutrophil recruitment [22], adherence [23], phagocytosis [24], and apoptosis 
[25] and natural killer cell activity [26-27].  In antigen-presenting cells, saliva reduces 
macrophage cytokine production [28-29], co-stimulatory molecule expression [28,30], 
phagocytosis [14], and nitric oxide production [26] and inhibits dendritic cell 
differentiation, maturation, and cytokine production [31-33].  Tick saliva also contains 
molecules that control host angiogenesis and wound healing to aid feeding [34-38].      
Prostaglandins are among the most abundant bioactive molecules in tick saliva 
[reviewed in 39].  Prostaglandin E2 (PGE2), which increases vasodilation [40] and 
decreases inflammation by regulating cytokine production [41-45], is found in high 
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concentration in tick saliva [39,46-50].  The exact role(s) of prostaglandins in tick saliva 
have not all been identified but salivary PGE2 has been shown to inhibit dendritic cell 
differentiation, maturation, and cytokine production [31-32] and T lymphocyte 
proliferation [47].   
To complete feeding, ticks must control the activities of immune and reparative 
cells in the feeding lesion.  PGE2 modulates the migratory activity of macrophages [51] 
and fibroblasts [52-54].  We have previously demonstrated that tick salivary gland extract 
(SGE) and saliva have different effects on platelet-derived growth factor (PDGF)-
stimulated fibroblast [15] and macrophage [14] migration.  Since PGE2 regulates 
macrophage and fibroblast migration, in this study we investigate if D. variabilis salivary 
PGE2 modulates the migratory activity of IC-21 murine macrophages and NIH3T3-
L1murine fibroblasts by using the PGE2 receptor antagonist AH 6809.  We also use this 
approach in evaluating the effects of salivary PGE2 on IC-21cytokine secretion.  IC-21 
cells were used in this study because they are a continuous monoclonal murine 
macrophage-like cell line which is very similar to macrophages in morphology [55].  
They also have phagocytic and cytolytic activities [56], express platelet-activating factor 




IC-21 murine peritoneal macrophages were maintained in 25 cm
2
 flasks or 100 
mm dishes in RPMI 1640 (MediaTech, Herndon, VA) supplemented with 10% fetal 
bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin. Macrophages 
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 free Hank’s balanced salt solution (HBSS) 
(Mediatech, Herndon, VA) and seeded at a density of 5 x 10
4  
or 6 x 10
4  
cells/ml. 
NIH3T3-L1 murine dermal fibroblasts were grown in 25 or 75 cm
2 
flasks in Dulbecco’s 
modified Eagle’s medium nutrient mixture F-12 (DMEM/F12) (MediaTech, Herndon, 
VA) supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin, and 




 free HBSS and 0.025% trypsin/0.02% EDTA 
(Mediatech, Herndon, VA) then seeded at a density of 5 x 10
4 
cells/ml.  
Collection of tick saliva  
Adult male and female ticks were purchased from Etco Services, Inc (Henderson, 
NC) and maintained in 96% humidity with a saturated K2SO4 solution at room 
temperature.  Ticks were fed on adult female New Zealand white rabbits (Harlan 
Laboratories, Prattville, AL) for 5-8 days following protocols approved by The 
University of Memphis Institutional Animal Care and Use Committee.  Partially 
engorged females (70-350 mg) were removed and attached to a microscope slide with 
double-sided adhesive tape.  Female ticks were injected with 10 μl of MOPS buffered 
tick saline (pH 7.0) containing 10 mM dopamine / 10 mM theophylline with 3% dimethyl 
sulfoxide (DMSO) [58].  Ticks that did not salivate 5 min post-injection were not used.  
Ticks salivating were injected a total of 3 times in 5 min intervals and saliva was 
collected in a 25 µl non-heparinized soda lime glass micropipette, kept on ice, and 
pooled. Total protein concentration of saliva was determined using a Bio-Rad Protein 
Assay based on the method of Bradford (Bio Rad Laboratories, Hercules, CA) and stored 
at -20
◦
C until used. 
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PGE2 measurement  
 To determine the amount of PGE2 in D. variabilis saliva and how saliva affects 
the amount of PGE2 secreted by macrophages, a competitive PGE2 Enzyme Immunoassay 
(EIA) Express kit (Cayman Chemical, Ann Arbor, MI) was used.  Macrophages were 
cultured at a density of 5 x 10
4 
cells/well in 24-well plates for 5 days and changed to 
medium containing 2% FBS 24 h prior to the experiment.  Cells were treated with vehicle 
phosphate buffered saline (PBS) or saliva (1.2 or 3.6 μg protein/ml) for 18 h.  The 
conditioned medium was collected then stored at -80
◦
C and PGE2 content was measured 
according to manufacturer’s instructions. Absorbance was read at 405 nm using a Bio-
Tek Elx808 Ultra Microplate Reader.  A standard curve linearized using a logit 
transformation and a linear regression fit was used to determine PGE2 concentrations. 
Cell migration assay  
The effects of salivary PGE2 on macrophage and fibroblast migration were 
assessed using blind well chemotaxis chamber assays (Neuro Probe, Gaithersburg, MD).  





 free HBSS.  Cells were removed from surface by pipetting and then 
resuspended in serum-free medium, counted, and diluted to a concentration of 1 x 10
5
 





 free HBSS and trypsinization for 5 min. Cells were also resuspended in serum-
free medium, counted, and diluted to a concentration of 1 x 10
5
 cells/ml. The lower 
chamber of the blind well (Neuro Probe, Gaithersburg, MD) was loaded with either 
serum-free medium or medium with 100 ng/ml (PDGF-BB) (ProSpec-Tany TechnoGene 
Ltd, East Brunswick, NJ) as the chemoattractant.  An 8 µm uncoated polycarbonate filter 
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(Neuro Probe, Gaithersburg, MD) was placed between the lower and upper chambers of 
each blind well. The upper chamber was loaded with 100 µl of the macrophage 
suspension pretreated for 30 min with vehicle (DMSO), saliva (2.4 µg protein/ml), or 
PGE2 (1 µM; Cayman Chemical, Ann Arbor, MI) in the absence or presence of the E and 
D prostanoid (EP and DP) receptor antagonist AH 6809 (10 µM; Cayman Chemical, Ann 
Arbor, MI).  For the fibroblast suspensions, 30 min pretreatments consisted of vehicle 
(DMSO), saliva (2.4 µg protein/ml), PGE2 (1 µM), or conditioned medium (CM) from 
macrophages treated with saliva (2.4 µg protein/ml) for 18 h (to allow PGE2 to 
accumulate) in the absence or presence of AH 6809.  The blind wells were incubated for 
4 h at 37
◦
C in humidified air with 5% CO2.  After the incubation period, the non-invading 
cells were removed from the upper surface of the filters with a cotton-tip applicator. The 
filters were placed upside-down on a microscope slide and the cells were fixed with 
100% methanol, stained with 0.4% crystal violet in 4% ethanol, and counted in five 
random high-power (40x) fields using a Nikon Labophot light microscope (Nikon, 
Melville, NY). Data were reported as the percentage of control cells migrating in 4 h. 
Cytokine array 
To evaluate the effects of PGE2 in the saliva-induced changes on macrophage 
cytokine secretion we used the RayBio
® 
Mouse Cytokine Antibody Array (Catalog # 
AAM-CYT-1-8) RayBiotech, Inc., Norcross, GA) which simultaneously detects 22 
cytokines.  Macrophages were cultured at a density of 5 x 10
4 
cells/ml in 6-well plates 
and grown to confluence.  Twenty-four hours prior to the experiment, cells were changed 
to medium containing 2% FBS.  Cells were treated with vehicle (DMSO), saliva (2.4 µg 
protein/ml), 10 µM AH 6809, saliva+AH 6809, 0.76 μg/ml lipopolysaccharide (LPS) 
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(InvivoGen, San Diego, CA), or saliva+LPS for 18 h.  LPS is a Gram-negative bacteria 
toxin which activates macrophages through Toll-like receptor 4 (TLR4). The conditioned 
medium was collected, and the cytokine content for each sample was determined 
according to manufacturer’s instructions.  Arrays were developed with kit detection 
buffer and exposed to Classic Blue Autoradiography Film X (Molecular Technologies, 
St. Louis, MO) for 0.5, 2.5, 1, and 5 min.  The intensities of signals for each cytokine 
were quantified by densitometry using ImageJ version 1.46 Windows (National Institutes 
of Health, Bethesda, MD, http://rsb.info.nih.gov/ij/). The vehicle-treated array was used 
as the reference array to which the signals of the other arrays were normalized.  Data are 
reported as relative expression levels for each exposure time.  
Mouse interleukin-1 beta (IL-1β) enzyme-linked immunosorbent assay (ELISA) 
To evaluate the effects of saliva on IL-1β secretion, we used a RayBio
® 
Mouse 
IL-1β ELISA Kit (Catalog # ELM-IL1beta-001 RayBiotech, Inc, Norcross, GA).  
Macrophages were cultured at a density of 5 x 10
4 
cells/well in 24-well plates and grown 
until confluent.  The cells were changed to medium containing 2% FBS 24 h prior to the 
experiment.  Macrophages were treated with vehicle (PBS) or saliva (1.2 or 3.6 μg 
protein/ml) and then stimulated for 18 h with 0.76 μg/ml LPS. The cells were then pulsed 
with 5 mM adenosine triphosphate (ATP) (activator of purinergic receptor P2X7) for 20 
min and cultured for an additional 3 h.  The conditioned medium was collected then 
stored at -80
◦
C and IL-1β content was measured according to manufacturer’s instructions. 
Absorbance was read at 450 nm using a Bio-Tek Elx808 Ultra Microplate Reader; data 
were normalized to the absorbance in controls and reported as the fold change in IL-1β 
secretion. 
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Cyclic adenosine monophosphate (cAMP) measurement 
 A cAMP competitive EIA assay kit (Cayman Chemical, Ann Arbor, MI) was 
utilized to determine intracellular cAMP concentrations.  Macrophages were cultured at a 
density of 5 x 10
4 
cells/well in 24-well plates for 5 days.  Cells were washed with serum-
free medium and then cultured in RPMI with 0.5 mM 3-Isobutyl-1-methylxanthine 
(IBMX) (Sigma-Aldrich, St. Louis, MO) for 30 min.  Macrophages were then pre-treated 
with AH 6809 for 15 min and challenged with vehicle (DMSO), saliva (1.2 and 3.6 μg 
protein/ml), or 3 µM PGE2 for 7.5 min.  Cells were lysed in 0.1 M HCL at room 
temperature for 20 min and dissociated by pipetting, and samples were collected and 
centrifuged at 1000 xg for 10 min at room temperature.  Cyclic AMP determination was 
performed according to manufacturer’s instructions. Absorbance was read at 405 nm 
using a Bio-Tek Elx808 Ultra Microplate Reader, and a standard curve was linearized 
using a logit transformation and a linear regression fit was used to determine cAMP 
concentrations. 
Statistical analysis 
 PGE2 and cAMP data are means ± standard errors of means (SEM) of 3 
experiments assayed in duplicate performed over several passages of cells.  Cell 
migration data are percentage of control values ± SEM of 3 experiments. Data for the 
cytokine array are presented as means ± SEM normalized to the vehicle treated array and 
reported as relative expression levels determined by densitometry for 2 exposure times. 
Statistical significance was determined by one-way ANOVA; Student Newman-Kuels 
post test was used for multiple comparisons employing Graph Pad Prism version 3.02 
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Windows (Graph Pad Software, San Diego CA, www.graphpad.com).  Differences in 
means were considered significant at p≤ 0.05. 
Results 
Tick saliva increases macrophage PGE2 secretion 
 PGE2 is one of the most important prostanoids that plays roles in both anti- and 
pro-inflammatory responses.  We used a PGE2 EIA assay to measure the effects of tick 
saliva on macrophage PGE2 secretion. Cells were treated for 18 h with vehicle (PBS) or 
saliva (1.2 or 3.6 μg protein/ml).  Saliva dose-dependently increased macrophage PGE2 
secretion with significance reached at 3.6 μg protein/ml.  Saliva (3.6 μg protein/ml) 
increased macrophage secretion of PGE2 from 0.1 ± 0.04 to 29 ± 4 ng/ml (Figure 1).  
Since PGE2 is found in the saliva of many tick species [31-32,39,46-50], we determined 
the total PGE2 concentration of the pooled D. variabilis saliva used in these experiments 
was 352 ± 9 ng/ml (Figure 1).  We used 12 ul/ml of the pooled saliva to deliver 3.6 μg 
protein/ml. Therefore if the PGE2 from the tick saliva is still present in our sample after 
18 h, it only accounts for approximately 1.2% of the total PGE2 in the sample. 
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Figure 1.  Tick saliva causes PGE2 secretion by macrophages.  Cells were treated with 
vehicle (PBS) or saliva for 18 h.  Saliva dose-dependently  increased macrophage 
secretion of PGE2 reaching signifigance (p<0.05) at 3.6 μg protein/ml, (*) p<0.01 when 
compared to vehicle control.  The PGE2 concentration of the pooled saliva used for all 
experiments was 352 ± 9 ng/ml which was diluted to deliver 3.6 μg protein/ml.  If still 
present in the sample, the PGE2 from the pooled saliva would only account for 
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Salivary PGE2 regulates macrophage and fibroblast migration 
To determine the role of PGE2 in the effects of saliva on macrophage migration, 
we utilized blind well chemotaxis chamber assays.  Cells were pretreated with vehicle 
(DMSO), saliva (2.4 µg protein/ml), or 1 µM PGE2 in the absence or presence of 10 µM  
AH 6809 for 30 min then loaded into the upper chamber.  The lower chamber was loaded 
with medium for basal migration or medium containing 100 ng/ml PDGF for stimulated 
migration.   PDGF increased the total number of cells migrating by (264 ± 33%) an effect 
enhanced by saliva consistent with previous observations in our lab [14] (Figure 2A).  
The saliva-induced increase in PDGF-stimulated macrophage migration was similar to 
the increase induced by PGE2 (Figure 2A). The PGE2 receptor antagonist AH 6809 
significantly reduced the stimulatory effects of saliva by (53 ± 30%) (Figure 2A).  This 
reduction was similar to the effects observed in cells treated with PGE2 in the presence of 
the receptor antagonist (58 ± 32%) (Figure 2A) which suggests the saliva-induced 
increased in macrophage migration was mediated by PGE2.   
Fibroblast migration is inhibited by PGE2 [52-54], saliva [13], and SGE [15].  
Therefore, we treated fibroblasts with saliva (2.4 µg protein/ml) in the presence or 
absence of 10 µM AH 6809 for 4 h to determine if the PGE2 content in D. variabilis 
saliva is responsible for this inhibition. We also treated these cells with conditioned 
medium from macrophages treated with saliva (2.4 µg protein/ml) for 18 h, since saliva 
induces macrophages to secrete substantial amounts of PGE2 (Figure 1).  The number of 
fibroblasts migrating in response to PDGF (346 ± 40%) was significantly reduced by 
saliva to (88 ± 11%) and conditioned medium from saliva-treated macrophages to (156 ± 
31%) (Figure 2B).  The inhibitory effects of saliva and macrophage conditioned medium 
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were similar to that of PGE2 and were antagonized by AH 6809 (Figure 2B).  This 
antagonism partially restored the migration of the saliva-treated cells (55 ± 17%) while 
there was full restoration in the cells treated with conditioned medium from saliva-treated 
macrophages (94 ± 21%) when compared to the PDGF-stimulated cells (Figure 2B).  
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Figure 2.  Saliva-induced effects on macrophage and fibroblast migration are PGE2 
receptor antagonist-sensitive.  (A) Macrophages were pretreated for 30 min with 
vehicle (DMSO), saliva (2.4 µg protein/ml), or PGE2 (1 µM) in the absence or presence 
of the PGE2 receptor antagonist AH 6809 (10 µM), and then incubated for 4 h.  PDGF 
increased the number of cells migrating, an effect enhanced by saliva and PGE2, (**) 
p<0.001 and (*) p<0.01 when compared to PDGF treatment only.  These effects were 
reversed by AH 6809, (**) p<0.001 when saliva treatment was compared to saliva + AH 
6809 and when PGE2 was compared to PGE2 + AH 6809.  (B) Fibroblast were pretreated 
for 30 min with vehicle (DMSO), saliva (2.4 µg protein/ml), PGE2 (1 µM), or 
conditioned medium from macrophages treated with saliva for 18h in the absence or 
presence of the AH 6809 (10 µM) using PDGF as the chemoattractant.  After 4 h, saliva, 
PGE2, and saliva-treated macrophage conditioned medium decreased fibroblast migration 
(CM), (**) p<0.001 when compared to PDGF treatment only. The effects of saliva were 
partially reversed by AH 6809; however the receptor antagonist fully restored the 
migration of cells treated with conditioned medium of saliva-treated macrophages (CM) 
similar to that of PGE2 in the presence of AH 6809, (**) p<0.001 when PGE2 was 
compared to PGE2 + AH 6809 and when CM was compared to CM + AH 6809, (#) 
p<0.05 when saliva was compared to saliva + AH 6809. Data are reported as the % 
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Tick saliva decreases macrophage cytokine secretion, a response sensitive to the 
PGE2 receptor antagonist AH 6809 
Macrophages regulate the inflammatory and cellular immune responses by 
producing cytokines which influence the activity of lymphocytes.  The pro-inflammatory 
cytokines tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), IL-1 beta (IL-1β), 
and PGE2 are mediators of the inflammatory response [59].  In macrophages, PGE2 has 
been shown to have inhibitory effects on TNF-α and IL-12 production but enhances the 
production of IL-6 [41-42] which has both pro and anti-inflammatory effects.  We used 
the RayBio
® 
Mouse Cytokine Antibody Array to simultaneously test the effects of saliva 
on LPS-stimulated secretion of 22 cytokines and the role of PGE2 in any saliva-induced 
changes in cytokine secretion.  Saliva (2.4 µg protein/ml) significantly inhibited the 
relative expression levels of secreted pro-inflammatory cytokines Rantes (CCL5) and 
TNF-α along with the soluble form of its receptor TNF Receptor I (sTNFRI) (Figure 3A 
and B).  Saliva also inhibited LPS-stimulated secretion of these cytokines (Figure 4A and 
B).  IL-1β is produced by activated macrophages, and this pro-inflammatory cytokine is 
an important mediator of the inflammatory response.  However, using a mouse IL-1β 
ELISA Kit, we show saliva increased LPS-stimulated secretion of IL-1β by 
approximately 1.5 fold when compared to the vehicle control (Figure 5).  Saliva had no 
significant effects on IL-6 and IL-12p40p70 cytokines which also regulate inflammation 
(Figure 3 and 4).  The inhibitory effects of saliva on CCL5, sTNFRI, and TNF-α, were 
significantly reversed by AH 6809 (Figure 3A and B) which implicates the involvement 
of PGE2 in these effects. 
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Figure 3. Saliva-induced decreases of CCL5, sTNFR1, and TNF-α secretion by 
macrophages are PGE2 receptor antagonist-sensitive.  Cells were treated with vehicle 
(DMSO), saliva (2.4 µg protein/ml), AH 6809 (10 µM), or saliva+AH 6809 for 18 h.  (A)  
Saliva reduced the relative expression levels of secreted CCL5, soluble TNF Receptor I 
(sTNFR1), and TNF-α which was reversed by AH 6809.  (B) Image of blots exposed to 
film for 2.5 min corresponding to the treatments in (A), cylinder= CCL5, oval= sTNFR1, 
and rectangle= TNF-α, (**) p<0.001 when compared to vehicle control and when saliva 
was compared to saliva+AH 6809.  Data are means ± SEM normalized to the vehicle 
treated array reported as relative expression levels determined by densitometry for 1 and 
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Figure 4.  Saliva reduces LPS-stimulated cytokine secretion by macrophages.  Cells 
were treated with vehicle (DMSO), saliva (2.4 µg protein/ml), LPS, or saliva + LPS for 
18 h.  (A)  Saliva significantly reduced the relative expression levels of CCL5, soluble 
TNF Receptor I (sTNFRI), and TNF-α at 0.5 and 1 min exposure times.  (B) Image of 
blotss exposed to film for 1 min corresponding to the treatments in (A), cylinder= CCL5, 
oval= sTNFRI, and rectangle= TNF-α, (#) p<0.05 when compared to vehicle control and 
when LPS was compared to LPS + saliva.  Data are means ± SEM normalized to the 
vehicle treated array reported as relative expression levels determined by densitometry 
for 0.5 and 1 min exposure times. 
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Figure 5.  Tick saliva increases IL-1β secretion by macrophages.  IL-1β is a pro-
inflammatory cytokine produced by activated macrophages. Cells were treated with 
vehicle (PBS) or saliva (1.2 or 3.6 μg protein/ml) and then stimulated for 18 h with 0.76 
μg/ml LPS. The cells were then pulsed with 5 mM ATP for 20 min and cultured for an 
additional 3 h.  Surprisingly, saliva dose-dependently increased IL-1β secretion but 
significance (p< 0.05) was achieved at 3.6 μg protein/ml, (*) p<0.05 when compared to 
vehicle.  Data are means ± SEM, n= 3 assayed in duplicate.   
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 Tick saliva mimics PGE2-stimulated intracellular cAMP production 
When PGE2 binds to G protein-coupled receptors EP2/ EP4, the effects are 
mediated through increases in the second messenger cAMP.  In macrophages, activation 
of PGE2 receptors are associated with increased migration [51] and inhibition of pro-
inflammatory cytokines [41-42,60-61].  Therefore, we used a cAMP EIA assay to 
examine how the saliva-induced effects on macrophage migration and cytokine secretion 
correlate with changes in intracellular cAMP levels. After 7.5 min, saliva (3.6 μg 
protein/ml) and 3 µM PGE2 significantly increased cAMP production 62 ± 9 and 87 ± 16 
pmol/ml respectively (Figure 6). The stimulatory effects of saliva and PGE2 were both 
substantially reversed by the receptor antagonist which decreased cAMP concentrations 
to 45 ± 17 and 17 ± 2 pmol/ml respectively (Figure 6).  This suggests that the PGE2 in 
tick saliva binds receptors EP2/ EP4 and mediates its effects through increases in 
intracellular cAMP production in the macrophages.  
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Figure 6.  Tick saliva increases intracellular cAMP levels in macrophages.  Cells 
were pretreated with AH 6809 (10 μM) for 15 min and challenged with vehicle (DMSO), 
saliva (1.2 and 3.6 μg protein/ml), or PGE2 (3 µM) for 7.5 min.  Saliva dose-dependently  
increased macrophage intracellular cAMP production and signifcance (p<0.05) was 
achieved at 3.6 μg protein/ml with stimulatory effects similar to that of PGE2, (**) 
p<0.001 when compared to vehicle control.  The stimulatory effects were reversed by AH 
6809, (*) p<0.01 when PGE2 was compared to PGE2 + AH 6809 and when saliva was 
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Discussion 
To sustain physical attachment for several days, ixodid ticks have evolved to 
produce saliva which contains biologically active molecules that modulate their host’s 
immune, inflammatory, hemostatic, and wound healing responses.  We have previously 
shown that tick salivary constituent(s) have differential effects on the migratory and 
signaling activities of fibroblasts and macrophages [13-15].   Both cells are important in 
the wound healing cascade; however macrophages are also key regulators of the 
inflammatory and immune responses.  In wound healing, they phagocytose apoptotic 
neutrophils which limit their cytotoxic contents from spilling and damaging surrounding 
tissue [62-63].  Macrophages (M2) also trigger the proliferative phase of wound healing 
by secreting cytokines and growth factors such as PDGF which recruits fibroblasts to the 
site of injury [64].  The cytokines they produce control the inflammatory and cellular 
immune responses by influencing the activation and function of T lymphocytes.   The 
lipid modulators they produce such as PGE2 also play a role in regulating these 
responses.  Here, we examined the role of PGE2 in D. variabilis saliva on the regulation 
of macrophage and fibroblast migration along with macrophage cytokine secretion by 
using the PGE2 receptor antagonist AH 6809.   
 It is well established that there is great similarity in the salivary components 
among different tick species.  One consistency is the presence of prostaglandins [39,46-
50], and particularly PGE2 in saliva which has been shown to regulate dendritic cell 
differentiation, maturation, and cytokine production [31-32] and inhibit T lymphocyte 
proliferation [47]. Our results indicate that D. variabilis saliva like other ixodid tick 
species contains a high concentration of PGE2 and stimulates PGE2 production by 
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macrophages.  Therefore, ticks not only secrete components in their saliva to regulate 
host responses but also their salivary components induce cells to produce and secrete 
immuno-modulatory, anti-hemostatic, and anti-inflammatory effectors such as PGE2.   
PGE2 has been shown to regulate the migratory activity of different cell types 
[51,54,65-66].  Therefore it is logical that the PGE2 content in tick saliva is responsible 
for our previous observation of the saliva-induced regulation of macrophage [14] and 
fibroblast migration [13,15]. We show the increased macrophage migration and 
decreased fibroblast migration are both sensitive to the PGE2 receptor antagonist AH 
6809.  These data are consistent with the studies showing differing effects of PGE2 on 
macrophage [51] and fibroblast [52-54] migration. In addition, fibroblasts treated with 
conditioned medium from saliva-treated macrophages had lower migratory rates, a 
response reversed by AH 6809.  AH 6809 fully restored the migratory activity of 
fibroblasts treated with conditioned medium from saliva-treated macrophages suggesting 
this response was mediated by PGE2.  However, AH 6809 partially restored the migration 
of the cells treated with saliva only, meaning the saliva-induced inhibition was also 
regulated by some other salivary constituent(s).  This is supported by our previous studies 
which have shown saliva treatment reduced migration in fibroblasts and cancer cells, a 
response that correlated with changes in downstream effectors of growth factor receptor 
signaling [13,15]. Our results demonstrating that saliva modulates migration in these cells 
are further substantiated by studies which identified changes in macrophage [67] and 
fibroblast [15] numbers at the feeding lesion.   
Whether or not PGE2 is a pro or anti-inflammatory mediator is controversial [41-
42,59,68-69].  Since it is imperative for ticks to control host responses, we believe the 
  62 
 
PGE2 in saliva dampens host inflammation.  From our observation of 22 cytokines, we 
show saliva reduces the LPS-stimulated secretion of pro-inflammatory cytokines CCL5, 
TNF-α, and soluble TNF Receptor I (sTNFRI).  CCL5 recruits macrophages, dendritic 
cells, basophils, eosinophils, mast cells, natural killer cells, and T lymphocytes to sites of 
inflammation and infection [70-71] where they either participate in resolving 
inflammation or provide cues for activation of the adaptive immune response.   The 
decrease in CCL5 was reversed by the PGE2 receptor antagonist consistent with a report 
showing that tumor-secreted PGE2 inhibits CCL5 production in macrophages [60].  
However, this reduction in CCL5 may be due to the chemokine binding protein, Evasin-
4, which interacts with CCL5 and CCL11 and has been identified in tick SGE [19].  By 
decreasing CCL5, ticks can prevent macrophages from recruiting other leukocytes to the 
feeding lesion, therefore dampening the host inflammatory and immune responses.         
Chiefly produced by macrophages, TNF-α is a pleiotropic cytokine that serves as a key 
mediator of inflammation.  It increases vascular permeability and cytokine production 
eliciting the recruitment of macrophages and neutrophils to sites of infection.  In 
neutrophils, TNF-α has been shown to induce proliferation and apoptosis [72].  It can 
also induce blood clotting [73] therefore serving as a mechanism of containment during 
an infection.  Low levels of TNF-α promote replacement or remodeling of damaged 
tissue by triggering fibroblast growth [74].  This cytokine can result in activation of an 
adaptive immune response since it contributes to the proliferative response in T 
lymphocytes [75].  However, the persistent presence of TNF-α can contribute to chronic 
inflammatory conditions as seen in rheumatoid arthritis (RA) [76].  We show saliva 
reduces the secretion of TNF-α and its receptor in macrophages, and this effect was 
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sensitive to the PGE2 receptor antagonist.  This is supported by evidence indicating that in 
macrophages PGE2 works in concert with IL-6 to inhibit TNF-α production in a murine 
arthritis/lupus model [41].  Surprisingly, saliva did not affect the secretion of IL-6 and IL-
12p40p70 or the anti-inflammatory cytokine IL-10 (data not shown).  We expected saliva 
to impose some change on IL-6 secretion because in RA it is considered pro-
inflammatory [41], and it is produced with TNF-α and IL-1β in other stress conditions 
[77].  Furthermore, both in vitro [78] and in vivo [77] studies have indicated the anti-
inflammatory effects of IL-6.   Since we have previously shown saliva increases the gene 
expression of anti-inflammatory cytokine IL-10 [14] which is indicative of an immune 
response shifted toward a T helper 2 phenotype [79], we anticipated saliva would 
increase the secretion of this cytokine but this effect was not observed (data not shown).  
Saliva did not reduce the IL-12 subunit IL-12p40p70 as we expected because PGE2 
inhibits IL-12 production in macrophages [42] and production of this cytokine drives a 
pro-inflammatory response characterized as a T helper 1 reaction [80].  However, we are 
currently investigating the secretion of these cytokines at earlier time points as in our 
gene expression study in Kramer et al. [14]. Also we evaluated how saliva influences the 
secretion of pro-inflammatory cytokine IL-1β.  The production of this cytokine is tightly 
regulated by a multi- protein complex called an inflammasome.  While saliva increases 
LPS-stimulated secretion of IL-1β, we have shown that the expression of the IL-1β 
receptor antagonist IL-1RN is also up-regulated and may serve as a countermeasure to 
any pro-inflammatory effects from this cytokine [14].    
PGE2 modulates cellular activities via G protein-coupled receptors EP1-4 whose 
effects are mediated through calcium mobilization and cAMP production.  In fibroblasts, 
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PGE2 activation of EP2 and EP4 receptors leads to increases in cAMP production and 
inhibition of migration [52-54] comparable to our observation of saliva-induced 
decreases in fibroblast migration.  We also observed the saliva-induced increases in 
cAMP production in macrophages correlated with the PGE2-mediated changes on 
migration and cytokine secretion.  Using RAW264.7 macrophages, Tajima et al., [51] 
shows that PGE2 regulates LPS-stimulate migration through the EP4 receptor supporting 
our rationale for the PGE2 content in tick saliva as the modulator of macrophage 
migration. In our study we used the PGE2 receptor antagonist AH 6809 which binds EP2 
but not EP4. However, we believe that the ability of AH 6809 to reverse the stimulatory 
effects of PGE2 and saliva on macrophage migration suggests that in IC-21 macrophages 
EP2 also plays a role. Also intracellular cAMP has been shown to have a central role in 
resolving inflammation [81-82]. The inhibitory effects of tumor-secreted PGE2 on 
macrophage CCL5 are mediated through cAMP [60] further supporting the idea that 
inhibitory effects of saliva on macrophage cytokine secretion are caused by PGE2 and 
mediated through cAMP.   
Conclusions 
To facilitate the feeding process, ticks and other arthropods have evolved a 
repository of pharmacologically active molecules in their saliva to modulate the host’s 
inflammatory and immune responses.  Our data illustrate the saliva-induced changes on 
macrophage and fibroblast migration and cytokine secretion in macrophages are sensitive 
to a PGE2 receptor antagonist suggesting these effects are mediated at least in part by 
PGE2 signaling through the second messenger cAMP.  This indicates the PGE2 content in 
tick saliva has roles in altering the migratory activity and cytokine profile of cells 
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involved inflammation and wounding healing.  These findings further demonstrate the 
complex nature of tick saliva and highlight the potential redundancy in the mechanisms 
utilized to regulate host responses.   
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ELISA: enzyme-linked immunosorbent assay; ATP: adenosine triphosphate; cAMP: 
cyclic adenosine monophosphate; SEM: means ± standard errors of means; EP2: E 
prostanoid receptor 2; EP4: E prostanoid receptor 4;  RA: rheumatoid arthritis 
Acknowledgements 
We are grateful to Bridget Sutton-Fisher for her assistance with the cytokine array data 
analysis and to Dr. Marjorie Rothschild for the helpful comments and suggestions on this 





  66 
 
References 
1. Coons LB, Alberti G: The Acari Ticks. In Microscopic Anatomy of Invertebrates 8B, 
Chelicerate Arthropoda. Harrison FW, Felix R. New York: Wiley-Liss; 1999:267-
514. 
 
2. Sonenshine DE: Biology of Ticks. New York: Oxford University Press; 1991. 
 
3. Kemp DH, Stone BF, Binnington KC: Tick attachment and feeding: Role of the 
mouthparts, feeding apparatus, salivary gland secretions, and host response. In 
Physiology of Ticks. Edited by Obenchain ED, Galun R. Oxford: Pergemon Press; 
1982: 119-168. 
 
4. Fontaine A, Diouf I, Bakkali N, Misse D, Pages F, Fusai T, Rogier C, Almeras L:  
Implications of haematophagous arthropods salivary proteins in host-vector 
interactions. Parasit Vectors 2011, 4:187.  
 
5. Anderson JF: Structure and mechanism in salivary proteins from blood-feeding 
arthropods. Toxicon 2010, 56:1120-1129. 
 
6. Nuttall PA, Labuda M: Saliva-assisted transmission of tickborne pathogens. In 
Ticks: Biology, Disease and Control. Edited by Bowman AS, Nuttall PA. Cambridge: 
Cambridge University Press; 2008:205-219. 
 
7. Brossard M, Wikel SK: Tick immunobiology. In Ticks: Biology, Disease and 
Control. Edited by Bowman AS, Nuttall PA. Cambridge: Cambridge University 
Press; 2008:186-204. 
 
8. Anderson LM, Valenzuela JG: Tick saliva: from pharmacology and biochemistry 
to transcriptome analysis and functional genomics. In Ticks: Biology, Disease and 
Control. Edited by Bowman AS, Nuttall PA. Cambridge: Cambridge University 
Press; 2008:92-107. 
 
9. Steen NA, Barker SC, Alewood PF: Proteins in the saliva of the Ixodida (ticks): 
pharmacological features and biological significance. Toxicon 2006, 47:1-20. 
 
10. Sauer JR, McSwain JL, Bowman AS, Essenberg RC: Tick salivary gland 
physiology. Annu Rev Entomol 1995, 40:245-267. 
 
11. Ribeiro JM: Blood-feeding arthropods: live syringes or inverterbrate 
pharmacologists? Infect Agents Dis 1995, 4:143-152. 
 
12. Ribeiro JM: Role of saliva in blood-feeding by arthropods. Annu Rev Entomol 
1987, 29:463-478. 
 
  67 
 
13. Poole NM,  Nyindodo-Ogari L, Kramer C, Coons LB, Cole JA: Effects of tick saliva 
on the migratory and invasive activity of Saos-2 osteosarcoma and MDA-MB-
231 breast cancer cells. Ticks Tick Borne Dis 2013, 4:120-127. 
 
14. Kramer C, Poole NM, Coons LB, Cole JA: Tick saliva regulates migration, 
phagocytosis, and gene expression in the macrophage-like cell line, IC-21. Exp 
Parasitol 2011, 127:665-671. 
 
15. Kramer C, Nahmias Z, Norman DD, Mulvihill TA, Coons LB, Cole JA: 
Dermacentor variabilis: regulation of fibroblast migration by tick salivary gland 
extract and saliva. Exp Parasitol 2008, 119:391-397. 
 
16. Vančová I, Hajnická V, Slovák M, Kocáková P, Nuttall PA:  Evasin-3-like anti-
chemokine activity in salivary gland extracts of ixodid ticks during blood-
feeding: a new target for tick control. Parasite Immunol 2010, 32:460-463. 
 
17. Dias JM, Losberger C, Dѐruaz M, Power CA, Proudfoot AE, Shaw JP: Structural 
basis of chemokine sequestration by a tick chemokine-binding protein: the 
crystal structure of the complex between evasin-1 and CCL3. PLoS ONE 2009, 
4(12):e8514.  
 
18. Dѐruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, Russo RC, Ferreira 
BR, Graham GJ, Shaw JP, Wells TN, Teixeira MM, Power CA, Proudfoot AE: Ticks 
produce highly selective chemokine binding proteins with antiinflammatory 
activity. J Exp Med 2008, 205:2019-2031. 
 
19. Hajnická V, Vančová IV, Kocáková P, Slovák M, Gasperik J, Slavikova M, Hails RS, 
Labuda M,  Nuttall PA: Manipulation of host cytokine network by ticks: a 
potential gateway for pathogen transmission. Parasitol 2005, 130:333-342. 
 
20. Vančová IV, Slovák M, Hajnická V, Labuda M, Simo L, Peterková K, Hails RS, 
Nuttall PA: Differential anti-chemokine activity of Amblyomma variegatum 
adult ticks during blood-feeding. Parasite Immunol 2007, 29:169-177. 
 
21. Frauenschuh A, Power CA, Dѐruaz M, Ferreira BR, Silva JS, Teixeira MM, Dias JM, 
Martin T, Wells TN, Proudfoot AE: Molecular cloning and characterization of a 
highly selective chemokine-binding protein from the tick Rhipicephalus 
sanguineus. J Biol Chem 2007, 282:27250-27258.  
 
22. Guo X, Booth CJ, Paley MA, Wang X, DePonte K, Fikrig E, Narasimhan S, 
Montgomery RR: Inhibition of neutrophil function by two tick salivary proteins. 
Infection and Immunity 2009, 77:2320-2329. 
 
23. Montgomery RR, Lusitani D, de Boisfleury Chevance A, Malawista SE: Tick saliva 
reduces adherence and area of human neutrophils. Infect Immun 2004, 72:2989-
2994. 
  68 
 
 
24. Ribeiro JM, Weis JJ, Telford SR: Saliva of the tick Ixodes dammini inhibits 
      neutrophil function. Exp Parasitol 1990, 70:382-388. 
 
25. Beaufays J, Adam B, Menten-Dedoyart C, Fievez L, Grosjean A, Decrem Y, Prevot 
PP, Santini S, Brasseur R, Brossard M, Vanhaeverbeek M, Bureau F, Heinen E, Lins 
L, Vanhamme L, Godfroid E: Ir-LBP, an Ixodes ricinus tick salivary LTB4-
binding lipocalin, interferes with host neutrophil function. PLoS One 2008, 
3(12):e3987. 
 
26. Kopecký J, Kuthejlová M: Suppressive effect of Ixodes ricinus salivary gland 
extract on mechanisms of natural immunity in vitro. Parasite Immunol 1998, 
20:169-174. 
 
27. Kubeš M, Fuchsberger N, Labuda M, Žuffová E, Nuttall PA:  Salivary gland 
extracts of partially fed Dermacentor reticulatus ticks decrease natural killer cell 
activity in vitro. Immunology 1994, 82:113-116.  
 
28. Brake DK, Pѐrez de Leόn AA: Immunoregulation of bovine macrophages by 
factors in the salivary glands of Rhipicephalus microplus. Parasit Vectors 2012, 
5:38. 
 
29. Chen G, Severo MS, Sohail M, Sakhon OS, Wikel SK, Kotsyfakis M, Pedra  JHF: 
Ixodes scapularis saliva mitigates inflammatory cytokine secretion during 
Anaplasma phagocytophilum stimulation of immune cells. Parasit Vectors 2012, 
5:229. 
 
30. Brake DK, Wikel SK, Tidwell JP, Pѐrez de Leόn AA: Rhipicephalus microplus 
salivary gland molecules induce differential CD86 expression in murine 
macrophages. Parasit Vectors 2010, 3:103. 
 
31. Oliveira CJ, Sá-Nunes A, Francischetti IM, Carregaro V, Anatriello E, Silva JS, de 
Miranda Santos IK, Ribeiro JM, Ferreira BR:  Deconstructing tick saliva. J Biol 
Chem 2011, 286:10960-10969. 
 
32. Sá-Nunes A, Andrѐ  B, Lucas DA, Conrads TP, Veenstra TD, Anderson JF, Mather 
TN, Ribeiro JM, Francischetti IM: Prostaglandin E2 is a major inhibitor of 
dendritic cell maturation and function in Ixodes scapularis saliva. J Immunol 
2007, 179:1497-1505. 
 
33. Cavassani KA, Aliberti JC, Dias AR, Silva JS, Ferreira BR: Tick saliva inhibits 
differentiation, maturation, and function of murine bone-marrow-derived 
dendritic cells. Immunology 2005, 114:235-245.  
 
  69 
 
34. Hajnická V, Vančová-Štibrániová IV, Slovák M, Kocáková P, Nuttall PA: Ixodid 
tick salivary gland products target host wound healing growth factors. Int J 
Parasitol 2011, 41:213-223. 
 
35. Francischetti IM: Platelet aggregation inhibitors from hematophagous animals. 
Toxicon 2010, 56:1130-1144. 
 
36. McEachron T, Mackman N: Tumors, ticks and tissue factor.  J Thromb Haemost 
2009, 7:1852-1854. 
 
37. Carneiro-Lobo TC, Koniq S, Machedo DE,  Nasciutti LE, Forni MF, Francischetti 
IM, Sogayar MC, Monteiro RQ: Ixolaris, a tissue factor inhibitor, blocks primary 
tumor growth and angiogenesis in a glioblastoma model. J Thromb Haemost 2009, 
7:1855-1864. 
 
38. Francischetti IM, Mather TN, Ribeiro JM: Tick saliva is a potent inhibitor of 
endothelial cell proliferation and angiogenesis. Thromb Haemost 2005, 94:167-
174.  
 
39. Bowman AS, Dillwith JW, Sauer JR: Tick salivary prostaglandins: presence, 
origin, and significance. Parasitol Today 1996, 12:388-396.  
 
40. Williams TJ: Prostaglandin E2, prostaglandin I2 and the vascular changes of 
inflammation. Br J Pharmacol 1979, 65:517-524. 
 
41. Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M: 
Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal 
macrophages and joints of pristane-treated mice and modulate TNF-α and IL-6 
production. J Leukoc Biol 2004, 76:227-236.  
 
42. Nataraj C, Thomas DW, Tilley SL, Nguyen MT, Mannon R, Koller BH, Coffman 
TM: Receptors for Prostaglandin E(2) that regulate cellular immune responses 
in the mouse. J Clin Invest 2001, 108:1229-1235. 
 
43. Betz M, Fox B: Prostaglandin E2 inhibits production of Th1 lymphokines but not 
of Th2 lymphokines. J Immunol 1991, 146:108-113. 
 
44. Hasler F, Bluestein HG, Zvaifler NJ, Epstein LB:   Analysis of the defects 
responsible for the impaired regulation of EBV-induced B cell proliferation by 
rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased 
sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E. J Immunol 
1983, 131:768-772. 
 
45. Tilden AB, Balch CM: A comparison of PGE2 effects on human suppressor cell 
function and on interleukin 2 function. J Immunol 1982, 129:2469-2473. 
 
  70 
 
46. Urioste S, Hall LR, Telford SR, Titus RG: Saliva of the Lyme disease vector, 
Ixodes dammini, blocks cell activation by a non-prostaglandin E2-dependent 
mechanism. J Exp Med 1995, 180:1077-1085. 
 
47. Inokuma H, Kemp DH, Willadsen P: Prostaglandin E2 production by the cattle 
tick (Boophilus microplus) into feeding sites and its effect on the response of 
bovine mononuclear cells to mitogen. Vet Parasitol 1994, 53:293-299. 
 
48. Ribeiro JM, Evans PH, Macswain JL, Sauer JR: Amblyomma americanum: 
characterization of salivary prostaglandin E2 and F2α by RP-HPLC/bioassay and 
gas chromatography-mass spectrometry. Exp Parasitol 1992, 74:112-116. 
 
49. Ribeiro JM, Makoul GT, Levine J, Robinson DR, Spielman A: Antihemostatic, anti-
inflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes 
dammini. J Exp Med 1985, 161:332-344. 
 
50. Higgs GA, Vane JR, Hart RJ, Potter C, Wilson RG:  Prostaglandins in the saliva of 
the cattle tick, Boophilus microplus (Canestrini) (Acarina, Ixodidae). Bull 
Entomol Res 1976, 66:665-670. 
 
51. Tajima T, Murata T, Aritake K, Urade Y, Hirai H, Nakamura M, Ozaki H, Hori M: 
Lipopolysaccharide induces macrophage migration via prostaglandin D2 and 
prostaglandin E2. J Pharmacol Exp Ther 2008, 326:493-501. 
 
52. Sandulache VC, Parekh A, Li-Korotky HS, Dohar JE, Hebda PA: Prostaglandin E2 
inhibition of keloid fibroblast migration, contraction, and transforming growth 
factor (TGF)-beta1-induced collagen synthesis. Wound Repair Regen 2007, 
15:122-133. 
 
53. Sandulache VC, Parekh A, Li-Korotky HS, Dohar JE, Hebda PA: Prostaglandin E2 
differentially modulates human fetal and adult dermal fibroblast migration and 
contraction: implication for wound healing. Wound Repair Regen 2006, 14:633-
643. 
 
54. Kohyama T, Ertl RF, Valenti V, Spurzem J, Kawamoto M, Nakamura Y, Veys T, 
Allegra L, Romberger D, Rennard SI: Prostaglandin E(2) inhibits fibroblast 
chemotaxis. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1257-1263. 
 
55. Mauel J, Defendi V: Infection and transformation of mouse peritoneal 
macrophages by simian virus 40. J Exp Med 1971, 134:335-350. 
 
56. Walker WS, Gandour DM: Detection and functional assessment of complement 
receptors on two murine macrophage-like cell lines. Exp Cell Res 1980, 129:15-
21.  
 
  71 
 
57. Walker WS: Separate Fc-receptors for immunglobins IgG2a and IgG2b on an 
established cell line of mouse macrophages. J Immunol 1976, 116:911-914. 
 
58. Needham GR, Sauer JR: Involvement of calcium and cyclic AMP in controlling 
ixodid tick salivary fluid secretion. J Parasitol 1979, 65:531-542.  
 
59. Lawrence T, Willoughby DA, Dilroy DW: Anti-inflammatory lipid mediators and 
insights into the resolution of inflammation. Nat Rev Immunol 2002, 2:787-795. 
 
60. Qian X, Zhang J, Liu J: Tumor-secreted PGE2 inhibits CCL5 production in 
activated macrophages through cAMP/PKA signaling pathway. J Biol Chem 
2011, 286:2111-2120. 
 
61. Kurihara Y, Endo H, Akahoshi T, Kondo H: Up-regulation of prostaglandin E 
receptor EP2 and EP4 subtypes in rat synovial tissues with adjuvant arthritis. 
Clin Exp Immunol 2001, 123: 323-330. 
 
62. Serhan CN, Savill J: Resolution of inflammation: the beginning programs the 
end. Nat Immunol 2005, 6:1191-1197. 
 
63. Nishio N, Okawa Y, Sakurai H, Isobe K: Neutrophil deletion delays wound repair 
in aged mice. Age (Dordr) 2005. 30:11-19. 
 
64. Werner S, Grose R: Regulation of wound healing by growth factors and 
cytokines. Physiol Rev 2003, 83:835-870. 
 
65. Zhao Q, Wang C, Zhu J, Wang L, Dong S, Zhang G, Tian J: RNAi-mediated 
knockdown of cyclooxygenase2 inhibits growth, invasion, and migration of 
SaOS2 human osteosarcoma cells: a case control study.  J Exp Clin Cancer Res 
2011 30:26. 
 
66. Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C: Role of 
prostaglandin E2 receptors in migration of murine and human breast cancer 
cells. Exp Cell Res 2003, 289:265-274. 
 
67. Szabό MP, Bechara GH: Sequential histopathology at the Rhipicephalus 
sanguineus tick feeding site on dogs and guinea pigs. Exp Appl Acarol 1999, 
23:915-928. 
 
68. Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory 
SA, Isakson PC: Selective neutralization of prostaglandin E2 blocks 
inflammation, hyperalgesia, and interleukin 6 production in vivo. J Exp Med 
1996, 184:883-891. 
 
  72 
 
69. Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D: Prostaglandin 
E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol 
Chem 1988, 263:5380-5384. 
 
70. Levy JA: The unexpected pleiotropic activities of RANTES.  J Immunol 2009, 
182: 3945-3946. 
 
71. Appay V, Rowland-Jones SL: RANTES: a versatile and controversial chemokine. 
Trends Immunol 2001, 22:83-87. 
 
72. Murray J, Barbara J, Dunkley S, Lopez A, Van Ostade X, Condliffe I, Haslett C, 
Chilvers E: Regulation of neutrophil apoptosis by tumor necrosis factor –alpha: 
requirements for TNF-R55 and TNF-R75 for induction of apoptosis in vitro. 
Blood 1997. 90:2772-2783. 
 
73. van der Poll T, Jansen PM, Van Zee KJ, Welborn MB III, de Jong I, Hack CE, 
Loetscher H, Lesslauer W, Lowry SF, Moldawer LL: Tumor necrosis factor –alpha 
induces activation of coagulation and fibrinolysis in baboons through an 
exclusive effect on the p55 receptor. Blood 1996, 88:922-927. 
 
74. Tracey K, Cerami A: Tumor necrosis factor: a pleiotropic cytokine and 
therapeutic target. Annu Rev Med 1994, 45:491-503. 
 
75. Christensen PJ, Rolfe MW, Standiford TJ, Burdick MD, Toews GB, Strieter RM: 
Characterization of the production of monocyte chemoattractant protein-1 and 
IL-8 in an allogeneic immune response. J Immunol 1993, 151:1205-1213. 
 
76. Feldmann M, Maini RN: Ant-TNF α therapy of rheumatoid arthritis: what have 
we learned? Annu Rev Immunol 2001, 19:163-196.  
 
77. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 the 
antiiflammatory cytokine required for controlling local and systemic acute 
inflammatory responses. J Clin Invest 1998, 101:311-320. 
 
78. Aderka D, Le JM, Vilcek J: IL-6 inhibits lipopolysaccharide-induced tumor 
necrosis factor production in cultured human monocytes, U937 cells, and in 
mice. J Immunol 1989, 143:3517-3523. 
 
79. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. 
Nat Rev Immunol 2008, 8:958-969. 
 
80. Ottonello L, Morone MP, Dapino P, Dallegri F: Cyclic  AMP-elevating agents 
down-regulate the oxidative burst induced by granulocyte-macrophage colony-
stimulating factor (GM-CSF) in adherent neutrophils. Clin Exp Immunol 1995, 
101:502-506. 
 
  73 
 
81. Moore AR, Wiloughby DA: The role of cAMP regulation in controlling 
inflammation. Clin Exp Immunol 1995, 101:387-389. 
 





























 Ixodid ticks molt into each stage of their life cycle after ingesting a blood meal 
which can be anywhere from 3-14 days depending on the stage and species.   To 
complete a blood meal, the tick must attach to the host which requires penetrating the 
host’s skin, inserting their mouthparts, rupturing blood vessels, and establishing a feeding 
lesion that extends into the dermis of the host.  Next a cement-like substance is secreted 
from the salivary glands that helps anchor the tick during feeding.  Throughout the 
feeding process, the tick continuously alternates between ingesting blood and salivating 
into the host.  Physical attachment to the host for an extended period of time and 
completion of the feeding process requires the tick to secrete bioactive molecules in their 
saliva that regulate the host’s immune, inflammatory, hemostatic, and wound healing 
responses.  The data presented in this dissertation indicate that the cocktail of bioactive 
molecules in tick saliva have global effects on the function of cancer, immune, and 
reparative cells.  
Cell migration is a highly integrated multi-step process regulated by different 
signaling pathways.  Disruption of the effectors in these pathways can prevent normal 
physiological events such as tissue repair or lead to the progression of various diseases 
like metastatic cancer.  In Chapter 2, our findings indicate that D. variabilis saliva 
inhibits the migratory activities of Saos-2 osteosarcoma and MDA-MB-231 (MB-231) 
breast cancer cells.  When comparing the inhibitory effects of saliva on these two cell 
lines, the MB-231 cells required a greater concentration of saliva.  The differences in the 
responsiveness of these cells to saliva appear to be, at least in part, influenced by EGFR 
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number as the EGFR is over-expressed in the MB-231 cells.  Our evaluation of the 
saliva-induced inhibition on Saos-2 and MB-231 migration correlated with decreases in 
the activities of the EGFR downstream effectors, ERK and Akt, and is consistent with 
observations that both ERK and Akt can regulate the migratory activity of cancer cells 
(Liu et al., 2012; Gan et al., 2010; Zhou et al., 2006; Price et al., 1999).  In Saos-2 cells, 
saliva reduces EGF activation of Akt which has been shown to play an important role in 
migration in these cells (Coltella et al., 2003).  ERK does not appear to regulate migration 
in Saos-2 cells, and saliva had no effect on ERK activity.  Basal MB-231 migration is 
ERK- dependent while EGF-stimulated migration is PI3K- and PLC-dependent (Price et 
al., 1999).  Saliva decreases ERK activity in the MB-231 cells; however Akt was not 
affected.  The inhibitory effect of saliva on ERK activity was comparable to the effects of 
the EGFR inhibitor PD 168393 and MEK inhibitor U0126.  Since activation of the EGFR 
plays a role in cell migration in a number of cells, these data suggest that the EGFR may 
be a common target for regulation by constituents in tick saliva. 
Wound healing is a normal physiological event in which the host’s tissue repairs 
itself after an injury (reviewed in Singer and Clark, 1999).  This intricate process consists 
of three overlapping phases: inflammatory, proliferative, and remodeling.  The 
inflammatory phase begins with the initial injury when blood vessels are disrupted 
leading to platelet activation, clot formation, and the release of growth factors.  
Neutrophils are the predominant cell in the inflammatory phase for the first 48 h of 
wound healing.  They phagocytose cell debris and bacteria, produce reactive oxygen 
species (ROS) to kill bacteria, release cytokines to attract macrophages, and release 
proteases to remove bacteria and injured tissue.  Neutrophils then undergo apoptosis and 
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are phagocytosed by macrophages that prevent the leakage of cytotoxic contents which 
result in more damage to the surrounding tissue.   
Macrophages are critically important in wound healing since they regulate the 
activities of other immune and reparative cells.  They arrive at the injury site around day 
3, and they phagocytose bacteria, cell debris, red blood cells, and apoptotic neutrophils 
becoming the predominant cell in the wound.  Macrophages trigger the proliferative 
phase by secreting cytokines and growth factors such as PDGF which recruits fibroblast 
to the injury. Once the fibroblasts migrate into the wound and become the predominant 
cell in the proliferative phase, they proliferate then synthesize and deposit collagen. 
Angiogenesis, granulation tissue formation, epithelialization, and wound contraction take 
place during the proliferative phase.  Fibroblasts secrete growth factors such as vascular 
endothelial growth factor (VEGF) that lead to the recruitment of epithelial cells. 
Fibroblasts then differentiate into myofibroblasts that continue to migrate across the 
wound causing wound contraction. The proliferative phase is followed by collagen 
remodeling, in the remodeling phase.  Macrophages and fibroblasts have essential roles in 
the wound healing response; therefore it would be very beneficial for ticks to utilize their 
salivary constituent(s) to delay wound healing by targeting macrophage and fibroblast 
function.  
Previously, we have shown that tick SGE and saliva modulate the activities of 
fibroblasts and macrophages to delay wound healing (Kramer et al., 2011 and 2008).  
PGE2 increases macrophage migration (Tajima et al., 2008) and decreases fibroblast 
migration (Sandulache et al., 2007 and 2006; Kohyama et al., 2001).  Our data are 
consistent with these findings as shown in Chapter 3.  We show that tick salivary PGE2 
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mediates the saliva-induced increase in macrophage migration and the decrease in 
fibroblast migration as these effects are reversed by the PGE2 receptor antagonist, AH 
6809.  PGE2 regulates fibroblast and macrophage migration via G protein-coupled 
receptors EP2/ EP4 which effects are mediated through increases in the second 
messenger cAMP.  In macrophages, saliva mimics the PGE2-stimulated increase of 
antagonist-sensitive intracellular cAMP production.  This illustrates that the PGE2 in tick 
saliva binds to host cell PGE2 receptors and stimulates cAMP levels affecting fibroblast 
and macrophage migration.  Collectively, our migration experiments show that the 
constituents in tick saliva can target the same physiological event; however, it appears 
these responses are mediated through different signaling pathways which commonly 
occur.  The ability of ticks to utilize their salivary constituents to modulate host responses 
by mitigating cell signaling proves to be advantageous for ticks during the feeding 
process.         
As with reparative cells in wound healing, cellular invasiveness is a crucial 
characteristic of a metastatic phenotype.  It is related to and encompasses migration but 
the cells must also move through the extracellular matrix (ECM) which requires the 
production of proteolytic enzymes.  In Chapter 2, we show that saliva inhibits the 
invasiveness of Saos-2, MB-231, and fibroblasts when stimulated with FBS.  However, 
saliva inhibited the migration of Saos-2 cells while eliciting a pro-migratory response in 
the MB-231 cells when FBS was used as the chemoattractant.  We determined saliva had 
no effect on cell viability in this study.  Since saliva had different effects on FBS-
stimulated MB-231 and Saos-2 migration, we conclude that the reduction in cell invasion 
is not simply a reflection of lower migratory rates. We believe the most likely 
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explanation is a decrease in the production of matrix metalloproteinases (MMPs) which 
are responsible for ECM degradation.  In the MB-231 cells, it has been shown that 
agonist-induced activation of (MMP)-9 results in suppressed migration and invasion 
(Tsai et al., 2012), and we show saliva decreases the expression of MMP-2 and 9 in 
fibroblasts supporting the idea that a salivary constituent(s) reduces MMP activity 
(Appendix B).  
  Another vital role of macrophages is the regulation of the immune responses and 
inflammation by secreting cytokines, growth factors, and non-protein molecules that 
modulate the activity of immune and reparative cells.  Macrophages secrete molecules 
such as TNF-α, IL-1β, IL-6, IL-12, IL-10, PDGF, CCL5, and PGE2 and some work in 
concert to reduce inflammation.  For example, IL-6 decreases the pro-inflammatory 
effects of IL-1β by increasing the expression of the IL-1β receptor antagonist (IL 1rn) 
and stimulates production of anti-inflammatory IL-10.  IL-10 in turns inhibits the 
production of other pro-inflammatory cytokines such as TNF-α and IFN-γ.  The pro-
inflammatory effects of TNF-α are decreased by PGE2 via EP2/EP4 receptors and IL-6.  
We have shown that tick saliva regulates gene expression in macrophages in a manner 
consistent with an immune response skewed toward a T helper 2 reaction, that is 
characterized by the production of anti-inflammatory cytokines IL-10 and IL-4 (Kramer 
et al., 2011).  PGE2 reduces CCL5 (Qian et al., 2011) and TNF-α (Akaogi et al., 2004) 
secretion in macrophages, an effect mediated by cAMP.  In Chapter 3 of this study we 
demonstrated that saliva reduces the secretion of TNF-α and the soluble form of its 
receptor sTNFRI.  Saliva also decreased the secretion of chemokine CCL5.  The 
reduction of these cytokines by saliva was reversed by AH 6809 and correlated with 
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changes in intracellular cAMP production that is associated with resolving inflammation 
(Addas et al., 1996; Moore et al., 1995).  These observations show the role of salivary 
PGE2 in the regulation of macrophage cytokine profile and the consequent effects on 
immune and reparative cells in wound healing. 
 The data in this dissertation indicate that saliva from D. variabilis has global 
effects on the migratory activities of different cell types.  Even though this regulation is 
global, it appears that the constituents in tick saliva can target and modulate different 
signaling pathways to regulate the same physiological process.  We also illustrate how 
one constituent, PGE2, regulates not only migration but the secretion of cytokines.   The 
redundancy emphasizes the fact that ticks must regulate the cellular population at the 
feeding lesion by releasing immuno-modulatory and anti-inflammatory molecules to 
control host responses in order to complete a blood meal. Targeting these aspects in 
vaccine or drug development could be instrumental in preventing tick attachment or their 
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Fig. 1.  Heat and protease inactivation of tick saliva prevents its effects on Saos-2 
migration.  Saos-2 cells were pretreated for 30 min with vehicle (PBS), saliva (0.4 μg 
protein/ml), saliva heated for 30 min at 75
◦
C, or saliva + 0.025% trypsin.  The cells were 
then placed in blind-well chambers in the presence of FBS.  After 4 h, saliva significantly 
inhibited Saos-2 migration.  This effect was not observed when heat and trypsin were 
used to denature the proteins in saliva, (a) p<0.05 when compared to vehicle control.  
Data are reported as the % control values and are  means + SEM, n=3.  These results 
suggest a protein (s) in tick saliva is responsible for the saliva-induced inhibition on Saos-
2 migration. Since PGE2 increases the migratory activity of these cells, this further 
supports tick saliva contains different constituents which regulate the same cellular 
activities.  
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Fig. 2. Tick saliva had no effect on colony formation in Saos-2 cells.  To determine if 
saliva affects the viability of Saos-2 cells, we used a clonogenic assay which shows the 
ability of the cells to divide and form colonies.  A 0.5% agarose solution consisting of 
Saos-2 feeding medium was poured in 6 well plates as the bottom feeding layer.  This 
layer was covered with a 0.3% agarose solution with feeding medium and Saos-2 cells at 
a density of 5 x 10
4 
cells/ml that were treated with saliva. After 1 week, saliva had no 
significant effect (p< 0.05) on Saos-2 colony formation.  Data are reported as the % 
control values and are  means + SEM, n=3.  These results in conjuction with the Saos-2 
cell number data in Chapter 2 support the conclusion that the saliva-induced decrease on 
Saos-2 migration was not due to saliva killing a percentage of the cells.   
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Fig. 3.  Tick saliva does not affect Akt activity in MDA-MB-231 breast cancer cells.  
MDA-MB-231 cells were pretreated with vehicle (PBS) or saliva for 30 min then 
challenged with 1, 10 and 100 ng/ml EGF for 15 min.  Saliva had no significant effect 
(p< 0.05) on EGF-activation of Akt.   Data are reported as the fold change from vehicle 
treated cells and are means ± SEM, n=3 assayed in triplicate.  
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Appendix B 
Hard ticks are obligate ectoparasites with a very complex feeding process.  After 
establishing a specialized feeding lesion, ticks pool feed by alternating between ingesting 
blood and secreting saliva into the host (Sonenshine, 1991).  For ticks to feed, they must 
control the wound healing cascade which involves immune cells, reparative cells, 
cytokines, growth factors, and extracellular matrix.  In wound healing there are three 
overlapping phases: inflammatory phase, proliferative phase, and remodeling phase.  The 
inflammatory phase begins with the initial injury. Blood vessels are disrupted leading to 
platelet activation, clot formation, and the release of growth factors (Singer and Clark, 
1999).  Consequently in a short period, chemoattractants are released and neutrophils 
migrate from the blood vessels to the wound site (Segal, 2005).  Neutrophils phagocytose 
cell debris and bacteria, produce reactive oxygen species to kill bacteria, release 
cytokines to attract macrophages, and release proteases to remove bacteria and injured 
tissue (Nathan, 2006).  After neutrophils perform their functions in wound healing, they 
undergo apoptosis and are phagocytosed by macrophages to limit cytotoxic contents from 
spilling and damaging surrounding tissue (Serhan and Savill, 2005; Nishio et al., 2005).  
Macrophages trigger the proliferative phase by secreting cytokines and growth factors 
such as platelet-derived growth factor which recruits fibroblasts to the injury (Werner and 
Grose, 2003).  Fibroblasts migrate into the wound were they proliferate, deposit new 
collagen, and secrete growth factors (chemoattractants) for other cells involved in the 
remodeling phase (Werner and Grose, 2003).  Here we examine the saliva-induced 
effects on the expression of fibroblast genes involved in the host wound healing response.  
We hypothesize that tick saliva will down regulate expression of genes critical to wound 
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healing. Our data from PCR arrays show a down-regulation of several integrin and matrix 
metalloproteinase genes as well as two collagen genes. In contrast, our data show an up-
regulation of the gene for collagen, type 1 alpha 1.  We conclude, as observed in other 
systems, ticks balance pro and anti-inflammatory mechanisms to regulate wound healing.  
Materials and methods 
Cell culture 
NIH3T3-L1 fibroblasts were grown in 100 mm dishes in Dulbecco’s modified 
Eagle’s medium nutrient mixture F-12 (DMEM/F12) (MediaTech, Herndon, VA) 
supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin, and were 




 free Hank’s balance salt solution (HBSS) and 









 Wound Healing PCR array (SABiosciences-Qiagen, Valencia, 
CA) was used to analyze the saliva-induced changes on the expression of fibroblast genes 
expected to be modified if saliva regulates wound healing.  Fibroblasts were treated with 
vehicle (PBS) or saliva (0.4 μg protein/ml) for 2 hr.  The cells were lysed with RNA 
Lysis Solution with 2-mercaptoethanol, and the RNA was isolated using the PureLink 
Micro-to-Midi total RNA Purification System (Gibco-Invitrogen, Carlsbad, CA).  1 μg of 
RNA was treated with DNase to remove contaminating genomic DNA, and cDNA was 




 strand kit (SABiosciences-Qiagen, Valencia, CA).  The 
template cDNA was characterized for up or down regulation of gene expression using 
human primers and RT
2 
SYBR green Master Mix (SABiosciences-Qiagen, Valencia, 
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CA).   The data were analyzed as relative changes in gene expression of the control and 
experimental groups when compared to the housekeeping gene (GAPDH).  Only genes 
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Fig. 1. Tick saliva up-regulates the expression of collagen1a1 in fibroblasts.  
Fibroblasts were treated with vehicle (PBS) or saliva (0.4 μg protein/ml) for 2 hr.  RNA 
was isolated from the treated cells then real-time PCR was performed using cDNA.  Tick 
saliva up-regulated the expression of  the collagen type 1 alpha 1(Col1a1) gene by 2.2 
fold in fibroblasts.  Saliva decreased the gene expression of collagen type 3 alpha 1 
(Col3a1) and collagen type 6 alpha 1 (Col6a1) however the changes were not relevant (2-
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Fig. 2. Tick saliva inhibits the expression of matrix metalloproteinase (MMP) 2 in 
fibroblasts.   Matrix metalloproteinases (MMPs) degrade the extracellular matrix which 
allows fibroblasts to enter the wound site.  RNA and real-time PCR were performed as 
indicated in Fig. 1.  Saliva down-regulated the expression of  the MMP 2 gene by 2.5 fold 
in fibroblasts treated for 2 h.  Saliva decreased the gene expression of  MMP 9 and 
increased the expression of MMP 13 and MMP 14 but the changes were not relevant (2-
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Fig. 3. Tick saliva up-regulates the expression of integrin alpha 3 (Itga3) and 
integrin beta 3 (Itgb3).  Integrins are transmembrane receptors which allows cells to 
attach to the extracellular matrix and other cells.  RNA and real-time PCR were 
performed as indicated in Fig. 1.  Tick saliva up-regulated the expression of  the Itga3 
and Itgb3 by 2.1 and 2.0 fold respectively.  Saliva induces changes in other integrin 
related proteins but the changes in gene expression were not relevant (2-fold or greater) 



























Fig. 4. Saliva-induced changes in the expression of extracellular matrix proteins.  
The integrity of the extracellular matrix, which is important for homeostasis, is 
maintained by several proteins.  RNA and real-time PCR were performed as indicated in 
Fig. 1.  Tick saliva decreased the expression of several extracellular matrix proteins but 
only extracellular matrix protein 1 (Ecm1) (2.0 fold) and sarcoglycan (Sgce) (2.6 fold) 
were relevant when compared to vehicle treated cells.  Ecm1 plays a role in angiogensis 
and interacts with other extracellular matrix proteins to maintain the intergity of the skin 
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